image_name
stringlengths 68
68
| type
stringclasses 2
values | gt_table
stringlengths 116
12.6k
|
|---|---|---|
bfa88b1ac92f83c2c1c9121c7c4ace424f30dcd3367483e650e9fc23e78e7aea.png | simple | <table><tr><td></td><td>Case 1</td><td>Case 2</td></tr><tr><td>Age at onset, years/gender</td><td>65/M</td><td>50/M</td></tr><tr><td>Education (years)</td><td>12</td><td>16</td></tr><tr><td>Years of follow-up</td><td>5</td><td>7</td></tr><tr><td>Clinical Dementia Rating score, total (0–3) for the first 2 years</td><td>0.5</td><td>0.5</td></tr><tr><td>Sentence repetition</td><td>5 phrases</td><td>6 phrases</td></tr><tr><td>Non-word repetition</td><td>intact</td><td>intact</td></tr><tr><td>Forward digit span</td><td>6</td><td>6</td></tr><tr><td>Backward digit span</td><td>5</td><td>4</td></tr><tr><td>Confrontation naming in SLTA, % correct</td><td>25 (anomia)</td><td>65 (anomia)</td></tr><tr><td>Auditory single-word comprehension in SLTA, % correct</td><td>100</td><td>100</td></tr><tr><td>Auditory complex sentence commands comprehension in SLTA, % correct</td><td>20 (auditory comprehension deficits)</td><td>50 (auditory comprehension deficits)</td></tr><tr><td>Reading comprehension of complex sentence commands in SLTA, % correct</td><td>20 (reading comprehension deficits)</td><td>20 (reading comprehension deficits)</td></tr><tr><td>Written naming in Kanji in SLTA, % correct</td><td>20 (agraphia)</td><td>20 (agraphia)</td></tr><tr><td>Dictation of short sentences, % correct</td><td>0 (agraphia)</td><td>0 (agraphia)</td></tr><tr><td>Calculation in SLTA, % correct</td><td>15 (acalculia)</td><td>10 (acalculia)</td></tr><tr><td>Ideational apraxia</td><td>present</td><td>present</td></tr><tr><td>Visuoconstructional disorder</td><td>not found</td><td>present</td></tr><tr><td>Visuoperceptual disorder</td><td>not found</td><td>not found</td></tr><tr><td>Episodic memory deficits</td><td>found (2 years postonset)</td><td>Found (4 years postonset)</td></tr></table> |
e9eac407a409728c26a2a7a64c13ea1429323f5ca7485ba5eb4311dd85ca3a77.png | simple | <table><tr><td>End point</td><td>3-Year estimate (%)</td><td>95% Confidence interval</td></tr><tr><td>Progression-free survival</td><td>83.0</td><td>(69.8, 98.8)</td></tr><tr><td>Overall survival</td><td>94.9</td><td>(89.5, 100)</td></tr><tr><td>Local recurrence-free survival</td><td>96.6</td><td>(92.1, 100)</td></tr><tr><td>Distant metastasis-free survival</td><td>89.8</td><td>(82.4, 97.9)</td></tr></table> |
81e0350c1969762aa9d15fefa9daf2c04d75a68f9761935af884d822a7d8dece.png | simple | <table><tr><td>Osteosarcoma subtype</td><td>Osteoblastic 105 (57.1%)</td><td>Chondroblastic 40 (21.7%)</td><td>Fibroblastic 21 (11.4%)</td><td>Telangiectatic 14 (7.6%)</td><td>Others 4 (2.2%)</td><td>Total 184 (100%)</td></tr><tr><td>Number of “Good responders” (%)</td><td>45</td><td>19</td><td>5</td><td>6</td><td>0</td><td>75 (40.8)</td></tr><tr><td>Number of ‘Poor responders’ (%)</td><td>60</td><td>21</td><td>16</td><td>8</td><td>4</td><td>109 (59.2)</td></tr><tr><td>Number of cases with amplification (% of subtype)1</td><td>7 (6.7)</td><td>3 (7.5)</td><td>7 (33.3)</td><td>2 (14.3)</td><td>0</td><td>19</td></tr></table> |
0c098da16383fe9e28b9c8c18e867bb733def759784f3aab5ff6112be90fcffa.png | simple | <table><tr><td>Criterion</td><td>Sensitivity (95% CI)</td><td>Specificity (95% CI)</td></tr><tr><td>1.00</td><td>100 (81.3-100.0)</td><td>75.14 (70.3-79.5)</td></tr><tr><td>1.50</td><td>100 (81.3-100.0)</td><td>80.83 (76.4-84.8)</td></tr><tr><td>2.00</td><td>100.0 (81.3-100.0)</td><td>84.44 (80.3-88.0)</td></tr><tr><td>2.50</td><td>100.0 (81.3-100.0)</td><td>87.2 (83.3-90.5)</td></tr><tr><td>3.00</td><td>100.0 (81.3-100.0)</td><td>90.28 (86.7-93.1)</td></tr><tr><td>3.50</td><td>100.0 (81.3-100.0)</td><td>92.50 (89.3-95.0)</td></tr><tr><td>4.00</td><td>88.89 (65.2-98.3)</td><td>93.89 (90.9-96.1)</td></tr><tr><td>4.50</td><td>88.89 (65.2-98.3)</td><td>95.56 (92.9-97.4)</td></tr><tr><td>5.00</td><td>88.89 (65.2-98.3)</td><td>95.83 (93.2-97.6)</td></tr></table> |
50d3ae4a625c1df9ceb6a8f4fac6c5bff0b7608ad702523461fa219657b4ee95.png | simple | <table><tr><td></td><td></td><td>PCLe < 45°</td><td>PCLe ≥ 45° <sup>a</sup></td></tr><tr><td>Release −</td><td>AP/gap</td><td>1.7 (0.5)</td><td>2.5 (0.8)</td></tr><tr><td></td><td>n</td><td>27</td><td>6</td></tr><tr><td>Release + <sup>b</sup></td><td>AP/gap</td><td>1.7 (0.4)</td><td>2.2 (0.4)</td></tr><tr><td></td><td>n</td><td>10</td><td>7</td></tr></table> |
50d0adbc6776d832d1f32763ded02d40fbe00369383033694231f499089ef031.png | simple | <table><tr><td> </td><td>HIP/PAP [95% CI]</td><td>NMP-22 [95% CI]</td><td>BTA [95% CI]</td></tr><tr><td>Sensitivity (%)</td><td>80.2 [71.4 - 86.8]</td><td>52.1 [42.2 - 61.8]</td><td>34.7 [25.9 – 44.7]</td></tr><tr><td>Specificity (%)</td><td>78.2 [69.9 - 84.6]</td><td>93.5 [86.5 - 97.0]</td><td>96.1 [89.0 - 98.6]</td></tr><tr><td>PPV (%)</td><td>75.7 [66.8 - 82.8]</td><td>89.3 [78.5 - 95.0]</td><td>91.7 [78.2 - 97.1]</td></tr><tr><td>NPV (%)</td><td>82.3 [74.2 - 88.2]</td><td>65.2 [56.7 – 72.7]</td><td>54.1 [45.7 – 62.3]</td></tr></table> |
7c38d9151acce9881b514a2e6f496226c6b72656d4f5bd42f29678b738329bbd.png | complex | <table><tr><td>Risk factors</td><td>Number of animals examined</td><td>Number of positive animals</td><td>95% CI</td><td><i>χ</i><sup>2</sup></td><td><i>p</i> value</td></tr><tr><td><i>Kebeles</i></td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Charicho</td><td>128</td><td>109 (85%)</td><td>—</td><td rowspan="3">1.402</td><td rowspan="3">0.705</td></tr><tr><td>Gute</td><td>128</td><td>88 (68.7%)</td><td>47.4–68.5</td></tr><tr><td> Yaye 01</td><td>128</td><td>94 (73.4%)</td><td>53.8–73.4</td></tr><tr><td><i>Sex</i></td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Female</td><td>249</td><td>290 (76.3%)</td><td>—</td><td rowspan="2">0.559</td><td rowspan="2">0.454</td></tr><tr><td>Male</td><td>135</td><td>101 (74.8%)</td><td>55.7–75.8</td></tr><tr><td><i>Age</i></td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Old</td><td>63</td><td>62 (98.4%)</td><td>—</td><td rowspan="3">6.154</td><td rowspan="3">0.046</td></tr><tr><td>Adult</td><td>194</td><td>153 (78.8%)</td><td>56.7–68.0</td></tr><tr><td>Young</td><td>127</td><td>76 (59.8%)</td><td>42.4–68.8</td></tr><tr><td><i>Body condition</i></td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Poor</td><td>32</td><td>32 (100%)</td><td>—</td><td rowspan="3">6.812</td><td rowspan="3">0.000</td></tr><tr><td>Medium</td><td>306</td><td>227 (74%)</td><td>46.6–58.9</td></tr><tr><td>Good</td><td>46</td><td>32 (69.5%)</td><td>69.1–100</td></tr><tr><td><i>Season</i></td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Wet</td><td>237</td><td>184 (77.6%)</td><td>—</td><td rowspan="2">1.023</td><td rowspan="2">0.312</td></tr><tr><td>Dry</td><td>147</td><td>107 (72.7%)</td><td>51.1–67.9</td></tr><tr><td><i>Total</i></td><td><i>384</i></td><td><i>291 (75.7%)</i></td><td> </td><td> </td><td> </td></tr></table> |
44b8944d7b282aca6383e32346b46c9e2dd4789ebdfd1b64f6348f0ddcb7963b.png | simple | <table><tr><td><i>Fusarium</i> Strains</td><td>PHS (mg/kg)</td><td>NIV (mg/kg)</td><td>FUSX (mg/kg)</td></tr><tr><td><i>F. asiaticum</i> SCK04 (#1) <sup>1,2</sup></td><td><0.15</td><td>4.84</td><td>67.0</td></tr><tr><td><i>F. asiaticum</i> SCK04 (#1, PDA) <sup>3</sup></td><td><0.15</td><td>5.24</td><td>42.4</td></tr><tr><td><i>F. asiaticum</i> SCK04 (#2) <sup>2</sup></td><td><0.15</td><td>2.65</td><td>12.1</td></tr><tr><td><i>F. asiaticum</i> SCK04 (#2, PDA) <sup>3</sup></td><td><0.15</td><td>3.26</td><td>20.8</td></tr><tr><td><i>F. culmorum</i> IFA450</td><td><0.15</td><td>0.15</td><td>0.74</td></tr><tr><td><i>F. equiseti</i> IFA33</td><td><0.15</td><td>0.23</td><td>0.86</td></tr><tr><td><i>F. equiseti</i> IFA34</td><td><0.15</td><td><0.012</td><td><0.04</td></tr><tr><td><i>F. equiseti</i> IFA63</td><td><0.15</td><td>0.07</td><td>0.16</td></tr><tr><td><i>F. equiseti</i> IFA64</td><td><0.15</td><td>0.28</td><td>1.23</td></tr><tr><td><i>F. equiseti</i> IFA157</td><td><0.15</td><td><0.012</td><td>0.05</td></tr><tr><td><i>F. equiseti</i> IFA336</td><td><0.15</td><td><0.012</td><td><0.04</td></tr><tr><td><i>F. equiseti</i> IFA408</td><td><0.15</td><td>0.036</td><td>0.15</td></tr><tr><td><i>F. equiseti</i> IFA409</td><td><0.15</td><td>0.10</td><td>0.33</td></tr><tr><td><i>F. equiseti</i> IFA410</td><td>0.23</td><td>60.0</td><td>110</td></tr><tr><td><i>F. graminearum</i> DAGZ5</td><td><0.15</td><td>0.67</td><td>20.0</td></tr><tr><td><i>F. graminearum</i> DAGZ8, gray mycelium<sup>4</sup></td><td>0.94</td><td>294</td><td>580</td></tr><tr><td><i>F. graminearum</i> DAGZ8, pink mycelium <sup>4</sup></td><td><0.15</td><td>5.00</td><td>212</td></tr><tr><td><i>F. graminearum</i> DAGZ13</td><td>0.17</td><td>212</td><td>>6000</td></tr><tr><td><i>F. graminearum</i> DAGZ13 (PDA) <sup>3</sup></td><td>0.29</td><td>238</td><td>>5000</td></tr><tr><td><i>F. graminearum</i> DAGZ22</td><td><0.15</td><td>0.37</td><td>43.6</td></tr><tr><td><i>F. graminearum</i> DAGZ23</td><td><0.15</td><td>2.71</td><td>49.6</td></tr><tr><td><i>F. graminearum</i> DAGZ24</td><td>0.49</td><td>88.8</td><td>788</td></tr><tr><td><i>F. graminearum</i> DAGZ25</td><td><0.15</td><td>0.10</td><td>4.84</td></tr><tr><td><i>F. graminearum</i> DAGZ29</td><td><0.15</td><td>10.3</td><td>242</td></tr><tr><td><i>F. graminearum</i> DAGZ31</td><td><0.15</td><td>44.0</td><td>107</td></tr><tr><td><i>F. graminearum</i> DAGZ36</td><td><0.15</td><td>0.25</td><td>21.9</td></tr><tr><td><i>F. graminearum</i> DAGZ37</td><td><0.15</td><td>1.91</td><td>33.4</td></tr><tr><td><i>F. graminearum</i> DAGZ39</td><td><0.15</td><td>0.14</td><td>1.68</td></tr><tr><td><i>F. graminearum</i> DAGZ46</td><td>1.44</td><td>399</td><td>1370</td></tr><tr><td><i>F. graminearum</i> DAGZ47</td><td><0.15</td><td>7.72</td><td>820</td></tr><tr><td><i>F. graminearum</i> DAGZ50 (#1) <sup>2</sup></td><td>1.65</td><td>199</td><td>283</td></tr><tr><td><i>F. graminearum</i> DAGZ50 (#2) <sup>2</sup></td><td>1.04</td><td>359</td><td>>1000</td></tr><tr><td><i>F. graminearum</i> DAGZ50 (PDA) <sup>3</sup></td><td>2.93</td><td>>900</td><td>>3000</td></tr><tr><td><i>F. graminearum</i> DAGZ55</td><td><0.15</td><td>32.2</td><td>378</td></tr><tr><td><i>F. graminearum</i> DAGZ62</td><td><0.15</td><td>13.4</td><td>133</td></tr><tr><td><i>F. graminearum</i> DAGZ63 (#1) <sup>2</sup></td><td><0.15</td><td><0.012</td><td>16.0</td></tr><tr><td><i>F. graminearum</i> DAGZ63 (#1, PDA) <sup>2,3</sup></td><td><0.15</td><td>0.32</td><td>0.568</td></tr><tr><td><i>F. graminearum</i> DAGZ63 (#2) <sup>2</sup></td><td><0.15</td><td>0.06</td><td>0.94</td></tr><tr><td><i>F. graminearum</i> NRRL 26752</td><td><0.15</td><td>1.46</td><td>2.42</td></tr><tr><td><i>F. graminearum</i> NRRL 26752 (PDA) <sup>3</sup></td><td><0.15</td><td>1.26</td><td>1.48</td></tr><tr><td><i>F. kyushuense</i> IFA189 (#1) <sup>2</sup></td><td>110</td><td>1370</td><td>1980</td></tr><tr><td><i>F. kyushuense</i> IFA189 (#2) <sup>2</sup></td><td>22.7</td><td>536</td><td>4560</td></tr><tr><td><i>F. kyushuense</i> NRRL 3509</td><td><0.15</td><td><0.012</td><td><0.04</td></tr><tr><td><i>F. kyushuense</i> NRRL 3510</td><td><0.15</td><td>0.03</td><td>0.11</td></tr><tr><td><i>F. kyushuense</i> NRRL 6490 (=Fn-2B)</td><td>10.0</td><td>404</td><td>2890</td></tr><tr><td><i>F. kyushuense</i> NRRL 6491</td><td>3.57</td><td>468</td><td>2930</td></tr><tr><td><i>F. kyushuense</i> NRRL 25348 (backup of 6490)</td><td>15.0</td><td>328</td><td>1440</td></tr><tr><td><i>F. kyushuense</i> NRRL 26204</td><td><0.15</td><td>0.07</td><td>0.15</td></tr></table> |
fd96319d953c65691ce03babb5ad1f9d7157e60494ef7a613614e385b12b2e7e.png | simple | <table><tr><td>Primers</td><td>Forward</td><td>Reverse</td></tr><tr><td>beta-actin</td><td>GCGCGGCTACAGCTTCA</td><td>CTTAATGTCACGCACGATTTCC</td></tr><tr><td>PPARgamma</td><td>GCTTTTGGCATACTCTGTGATCTC</td><td>GGTGGCCATCCGCATCT</td></tr><tr><td>VEGF-A</td><td>GGGCAGAATCATCACGAAGT</td><td>TGGTGATGTTGGACTCCTCA</td></tr><tr><td>CD105</td><td>CTCTCCAGGCATCCAAGCAA</td><td>CAGGCTGGAATTGTAGGCCA</td></tr><tr><td>CD31</td><td>GCTGACCCTTCTGCTCTGTT</td><td>ATCTGGTGCTGAGGCTTGAC</td></tr><tr><td>HIF-1alpha</td><td>GCCAGACGATCATGCAGCTA</td><td>ATCCATTGATTGCCCCAGC</td></tr><tr><td>IL-1beta</td><td>TCAGCCAATCTTCATTGCTCAA</td><td>TGGCGAGCTCAGGTACTTCTG</td></tr><tr><td>Wnt5a</td><td>CAAAGCAACTCCTGGGCTTA</td><td>CCTGCTCCTGACCGTCC</td></tr></table> |
a4ebb6e3e42e27bc77d6cf5e541a441bb14e492fb77e49d0f727e7d0517978ec.png | complex | <table><tr><td>Mobile phone prevalence in the control group</td><td colspan="4">Detectable Odds Ratio (Cases : Controls)</td></tr><tr><td></td><td>480:960</td><td>380 : 760</td><td>300 : 600</td><td>250 : 500</td></tr><tr><td>0.05</td><td>2.0</td><td>2.2</td><td>2.4</td><td>2.6</td></tr><tr><td>0.10</td><td>1.7</td><td>1.8</td><td>2.0</td><td>2.1</td></tr><tr><td>0.15</td><td>1.6</td><td>1.7</td><td>1.8</td><td>1.9</td></tr><tr><td>0.20</td><td>1.5</td><td>1.6</td><td>1.7</td><td>1.8</td></tr><tr><td>0.25</td><td>1.5</td><td>1.6</td><td>1.7</td><td>1.7</td></tr><tr><td>0.30</td><td>1.5</td><td>1.5</td><td>1.6</td><td>1.7</td></tr><tr><td>0.35</td><td>1.5</td><td>1.5</td><td>1.6</td><td>1.7</td></tr></table> |
c1b09cad2075371f85c9e2e594d8c74fd306e6af0bfabb347c68d95fe6f6c046.png | complex | <table><tr><td>Clinical features</td><td>Survivors (n = 93)</td><td>Non survivors (n = 96)</td><td>p value</td></tr><tr><td>Demographic factors</td><td> </td><td> </td><td> </td></tr><tr><td>Mean age</td><td>59.3 ± 18.6</td><td>61.0 ±17.4</td><td>0.52</td></tr><tr><td>≥ 65 years age</td><td>48 (52%)</td><td>52 (54%)</td><td>0.73</td></tr><tr><td>Gender male/female</td><td>55/38</td><td>55/41</td><td>0.79</td></tr><tr><td>ATS major criteria</td><td> </td><td> </td><td> </td></tr><tr><td>Use of mechanicalventilation</td><td>18 (19%)</td><td>29 (30%)</td><td>0.08</td></tr><tr><td>Septic shock</td><td>23 (25%)</td><td>59 (61%)</td><td>< 0.001</td></tr><tr><td>History</td><td> </td><td> </td><td> </td></tr><tr><td>Prior antibiotic use</td><td>14 (15%)</td><td>26 (27%)</td><td>0.04</td></tr><tr><td>Comorbids</td><td>76 (82%)</td><td>84 (88%)</td><td>0.27</td></tr><tr><td colspan="3">Physical examination findings</td><td> </td></tr><tr><td>Blood pressure ≤90/60 mmHg</td><td>25 (27%)</td><td>30 (31%)</td><td>0.51</td></tr><tr><td>Pulse ≥ 120/min</td><td>32 (34%)</td><td>37 (39%)</td><td>0.55</td></tr><tr><td>Respiratory Rate30/min</td><td>56 (60%)</td><td>57 (59%)</td><td>0.95</td></tr><tr><td colspan="2">Laboratory findings</td><td> </td><td> </td></tr><tr><td>Blood urea nitrogen ≥30 mg/dl</td><td>44 (47%)</td><td>59 (61%)</td><td>0.03</td></tr><tr><td>Creatinine > 1.5 mg/dL</td><td>48 (52%)</td><td>53 (55%)</td><td>0.25</td></tr><tr><td>Hematocrit <30%</td><td>22 (24%)</td><td>37 (39%)</td><td>0.03</td></tr><tr><td>Na <130 mmol/L</td><td>22 (24%)</td><td>28 (29%)</td><td>0.39</td></tr><tr><td>Arterial pH <7.35</td><td>28 (30%)</td><td>32 (33%)</td><td>0.63</td></tr><tr><td colspan="2">Radiographic findings</td><td> </td><td> </td></tr><tr><td>Pleural effusion</td><td>32 (34%)</td><td>38 (40%)</td><td>0.46</td></tr><tr><td>Bilateral involvement</td><td>36 (39%)</td><td>53 (55%)</td><td>0.07</td></tr><tr><td>Multilobar involvement</td><td>28 (30%)</td><td>38 (40%)</td><td>0.22</td></tr><tr><td>Mean APACHE II score</td><td>19.1 ±6.0</td><td>28.2 ±7.0</td><td><0.001</td></tr><tr><td>APACHE II score ≥ 20</td><td>38 (41%)</td><td>80 (83.0%)</td><td><0.001</td></tr></table> |
6ee32d911559bb68aea0e3c7df15868fc642492fad2d226e8fe5ee47ee0feb49.png | simple | <table><tr><td>Specimen</td><td>D/mm</td><td>t/mm</td><td>L/mm</td><td>L/D</td><td>RP<sub>RCA</sub>/%</td><td>RP<sub>RFA</sub>/%</td></tr><tr><td>FC-N-T1</td><td>100</td><td>4</td><td>500</td><td>5</td><td>0</td><td>0</td></tr><tr><td>FC-N-T2</td><td>100</td><td>5</td><td>500</td><td>5</td><td>0</td><td>0</td></tr><tr><td>FC-Ra-T1</td><td>100</td><td>4</td><td>500</td><td>5</td><td>100</td><td>0</td></tr><tr><td>FC-Ra-T2</td><td>100</td><td>5</td><td>500</td><td>5</td><td>100</td><td>0</td></tr><tr><td>FC-Rb-T1</td><td>100</td><td>4</td><td>500</td><td>5</td><td>100</td><td>100</td></tr><tr><td>FC-Rb-T2</td><td>100</td><td>5</td><td>500</td><td>5</td><td>100</td><td>100</td></tr></table> |
674c4952e15faf14de4d48d893de7bd0f3e9ecd9b31056c65cff32a9781637fd.png | simple | <table><tr><td>ICD-10-GM code</td><td>Corresponding diagnosis</td></tr><tr><td>I50.0</td><td>Right ventricular failure</td></tr><tr><td>I50.00</td><td>Primary right ventricular failure</td></tr><tr><td>I50.01</td><td>Secondary right ventricular failure</td></tr><tr><td>I50.1</td><td>Left ventricular failure</td></tr><tr><td>I50.11</td><td>NYHA class I</td></tr><tr><td>I50.12</td><td>NYHA class II</td></tr><tr><td>I50.13</td><td>NYHA class III</td></tr><tr><td>I50.14</td><td>NYHA class IV</td></tr><tr><td>I50.19</td><td>NYHA class not specified</td></tr><tr><td>I50.9</td><td>Heart failure, unspecified</td></tr><tr><td>I11.0</td><td>Hypertensive heart disease with (congestive) heart failure</td></tr><tr><td>I13.0</td><td>Hypertensive heart and renal disease with (congestive) heart failure</td></tr><tr><td>I13.2</td><td>Hypertensive heart and renal disease with both (congestive) heart failure and renal failure</td></tr></table> |
910c20e1e4c39c800b8553b23bf64e55197159d995063a88d85aa4957af959db.png | simple | <table><tr><td>Author</td><td>RAQ criteria for radiological bias</td><td>Association between malalignment and worse outcome</td><td>Sample size</td><td>Alignment data</td><td>Findings</td></tr><tr><td>Parratte et al. (2010)</td><td>Low risk</td><td>No</td><td>398</td><td>292 knees classed as mechanically aligned 0° ± 3. 10 knees in the outlier group (beyond 0° ÷ 3°</td><td>15.4 % revision rate in the mechanically aligned group. 13 % in the outlier group (p = 0.88). No association between malalignment and revision</td></tr><tr><td>Bonner et al. (2011)</td><td>Low risk</td><td>No</td><td>458</td><td>372 knees were classified as mechanically aligned (0° ± 3°). 86 knees were within the malaligned group</td><td>33 revisions for aseptic loosening. Kaplan–Meier survival analysis showed a weak tendency towards improved survival with restoration of a neutral mechanical axis, <i>but this did not reach statistical significance (p</i> <i>=</i> <i>0.47)</i></td></tr><tr><td>Magnussen et al. (2011)</td><td>Low risk</td><td>No</td><td>553</td><td>181 patients were in varus alignment, 352 were in neutral alignment and 20 were in valgus alignment</td><td>No <i>statistically significant difference</i> in revision rates between the three groups (p = 0.15)</td></tr></table> |
e4fcf1603f660961998d4bc8b399a4f20d9dc7af7b206e8dcacea2857c55457d.png | simple | <table><tr><td></td><td>No. of reads</td><td>No. of bases(bp)</td></tr><tr><td>Leaf</td><td>47,587,040</td><td>4,758,704,000</td></tr><tr><td>root</td><td>52,497,000</td><td>5,249,700,000</td></tr><tr><td>stem</td><td>59,385,462</td><td>5,938,546,200</td></tr><tr><td>Total raw data</td><td>159,469,502</td><td>15,946,950,200</td></tr><tr><td>Total high-quality data</td><td>154,439,892</td><td>15,264,422,138</td></tr><tr><td>Average high-quality read length (bp)</td><td>98.84</td><td></td></tr><tr><td>Average length of unigenes (bp)</td><td>895.05</td><td></td></tr><tr><td>Range of unigenes length (bp)</td><td>201-13,149</td><td></td></tr><tr><td>Unigenes > = 200 bp</td><td>186,324</td><td>166,768,907</td></tr><tr><td>N50 (bp)</td><td>1,524</td><td></td></tr></table> |
0310382c994edf720c385b4715c1349fd2f445650deb2d8ecc38799f3d702d3c.png | complex | <table><tr><td rowspan="2"></td><td></td><td colspan="2">Range</td><td colspan="3">Drying platform</td></tr><tr><td>Average</td><td>Min</td><td>Max</td><td>Rack</td><td>Black tarpaulin</td><td>Cement floor</td></tr><tr><td>OTA level (μg/kg)</td><td>0.569 ± 0.3</td><td><LD</td><td>13.4</td><td>0.459 ± 0.04 <sup>a</sup></td><td>0.665 ± 0.023 <sup>a</sup></td><td>0.584 ± 0.026 <sup>a</sup></td></tr></table> |
2e242911aa84ab8edc5752abe85feccf6e64a5c42b86d151002921483e451088.png | simple | <table><tr><td></td><td>Control group (<i>n</i> = 16)</td><td>PCOS (<i>n</i> = 43)</td></tr><tr><td>Age (years)</td><td>24.3 ± 4.1</td><td>25.3 ± 4.5</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>22.8 ± 3.0</td><td>24.5 ± 3.1</td></tr><tr><td>Waist circumference (cm)</td><td>80.3 ± 7.9</td><td>85.2 ± 10.7</td></tr><tr><td>Hip circumference (cm)</td><td>99.7 ± 7.3</td><td>101.6 ± 8.4</td></tr><tr><td>FFM (kg)</td><td>45.5 ± 5.1</td><td>46.7 ± 6.0</td></tr><tr><td>FM (kg)</td><td>18.6 ± 6.6</td><td>22.6 ± 7.2<sup>∗</sup></td></tr><tr><td>LDL cholesterol (mg/dl)</td><td>86.9 ± 20.4</td><td>100.5 ± 40.9</td></tr><tr><td>TG (mg/dl)</td><td>70.4 ± 17.1</td><td>78.7 ± 39.7</td></tr><tr><td>Glucose 0′ OGTT (mg/dl)</td><td>89 ± 6.8</td><td>88.2 ± 6.6</td></tr><tr><td>Glucose 30′ OGTT (mg/dl)</td><td>128.5 ± 24.6</td><td>145 ± 28.5<sup>∗</sup></td></tr><tr><td>Glucose 60′ OGTT (mg/dl)</td><td>97 ± 22.7</td><td>123.5 ± 35.8<sup>∗</sup></td></tr><tr><td>Glucose 120′ OGTT (mg/dl)</td><td>92 ± 15.6</td><td>95.7 ± 21.6</td></tr><tr><td>Insulin 0′ OGTT (<i>μ</i>IU/ml)</td><td>11.9 ± 5.5</td><td>11.5 ± 4.7</td></tr><tr><td>Insulin 30′ OGTT (<i>μ</i>IU/ml)</td><td>63.7 ± 28.5</td><td>89.3 ± 56.7</td></tr><tr><td>Insulin 60′ OGTT (<i>μ</i>IU/ml)</td><td>58.6 ± 49.2</td><td>84.4 ± 51.5<sup>∗</sup></td></tr><tr><td>Insulin 120′ OGTT (<i>μ</i>IU/ml)</td><td>35.8 ± 16.9</td><td>56.4 ± 49.6</td></tr><tr><td>HOMA-IR</td><td>2.6 ± 1.2</td><td>2.5 ± 1.0</td></tr><tr><td>HOMA-B</td><td>175.1 ± 80.7</td><td>193 ± 186.3</td></tr><tr><td>Matsuda index</td><td>5.37 ± 1.7</td><td>4.8 ± 2.1</td></tr><tr><td>Follicle-stimulating hormone (IU/l)</td><td>5.8 ± 2.8</td><td>4.5 ± 1.4</td></tr><tr><td>Luteinizing hormone (IU/l)</td><td>3.7 ± 1.3</td><td>6.3 ± 3.9<sup>∗</sup></td></tr><tr><td>Total testosterone (ng/ml)</td><td>0.5 ± 0.2</td><td>0.8 ± 0.4<sup>∗</sup></td></tr><tr><td>SHBG (nmol/l)</td><td>48.0 ± 19.1</td><td>45.4 ± 22.6</td></tr><tr><td>FAI</td><td>4.3 ± 2.2</td><td>8.4 ± 5.9<sup>∗</sup></td></tr><tr><td>Prolactin (ng/ml)</td><td>14.4 ± 6.8</td><td>15.2 ± 9.0</td></tr><tr><td>Betatrophin 0′ (ng/ml)</td><td>0.92 ± 0.35</td><td>0.85 ± 0.33</td></tr><tr><td>Betatrophin 120′ (ng/ml)</td><td>1.15 ± 0.42<sup>#</sup></td><td>0.88 ± 0.32<sup>∗</sup></td></tr></table> |
dd27259e6171d34798cf3509d5fe6dc06b75b61cbda1b34a963e2011b784db9e.png | simple | <table><tr><td>Patient characteristics</td><td>Result</td></tr><tr><td>Patients (<i>n</i>)</td><td>18</td></tr><tr><td>Mean age (range)</td><td>62 (41–89)</td></tr><tr><td>Sex (<i>n</i> male/female)</td><td>12/6</td></tr><tr><td>Body mass index (kg/m<sup>2</sup>)</td><td>22.2 ± 3.7</td></tr><tr><td>The combined surgical risk factors:</td><td></td></tr><tr><td>Receiving treatment for other cancers</td><td>3</td></tr><tr><td>Age >85 years old and refusal of surgery</td><td>4</td></tr><tr><td>Hemophilia</td><td>1</td></tr><tr><td>Coronary heart disease</td><td>6</td></tr><tr><td>End-stage renal disease receiving hemodialysis</td><td>2</td></tr><tr><td>Dilated cardiomyopathy with heart failure</td><td>2</td></tr><tr><td>Mean follow-up (range), months</td><td>26.8 (12–56)</td></tr><tr><td>Mean tumor size (range), cm</td><td>3.3 (1.4–4.6)</td></tr><tr><td>Tumor location (right/left)</td><td>10/8</td></tr><tr><td>Pathology:</td><td></td></tr><tr><td>Clear cell RCC</td><td>14</td></tr><tr><td>Papillary RCC</td><td>3</td></tr><tr><td>Chromophobe RCC</td><td>1</td></tr><tr><td>Operative time (min)</td><td>67 ± 18</td></tr><tr><td>Complication</td><td></td></tr><tr><td>Nausea</td><td>3</td></tr><tr><td>Pain</td><td>4</td></tr><tr><td>Subcapsular hemorrhage</td><td>1</td></tr><tr><td>Retroperitoneal errhysis</td><td>1</td></tr></table> |
78db32b713cfd7a333cd4a937a1255aeb159372422f851ffcfc65daf566aa741.png | complex | <table><tr><td colspan="2">Demographic</td><td></td></tr><tr><td rowspan="2">Patients (n)</td><td rowspan="2">Hips (n)</td><td>196</td></tr><tr><td>225</td></tr><tr><td rowspan="3">Age</td><td>Mean (SD, range)</td><td>60.3 (10.3, 25 to 84)</td></tr><tr><td><50 years</td><td>25 (15.7%)</td></tr><tr><td>≥50 years</td><td>171 (84.3%)</td></tr><tr><td rowspan="2">Sex</td><td>Male</td><td>181 (92.3%)</td></tr><tr><td>Female</td><td>15 (7.7%)</td></tr><tr><td rowspan="2">Diagnosis</td><td>Primary OA</td><td>145 (64.9%)</td></tr><tr><td>Other</td><td>80 (35.1%)</td></tr><tr><td rowspan="7">Femoral diameter</td><td>Median (range)</td><td>53 mm (51 to 61)</td></tr><tr><td>51 mm</td><td>88</td></tr><tr><td>53 mm</td><td>73</td></tr><tr><td>55 mm</td><td>33</td></tr><tr><td>57 mm</td><td>17</td></tr><tr><td>59 mm</td><td>13</td></tr><tr><td>>59 mm</td><td>1</td></tr><tr><td rowspan="3">Preoperative ROM</td><td>Mean (SD, range)</td><td>124° (22°, 10° to 276°)</td></tr><tr><td><100°</td><td>81 (43.4%)</td></tr><tr><td>≥100°</td><td>131 (56.6%)</td></tr><tr><td rowspan="3">Cup coverage</td><td>Mean (SD, range)</td><td>31.4° (6.8°, 10.7° to 52.0°)</td></tr><tr><td><25°</td><td>34 (28.1%)</td></tr><tr><td>≥25°</td><td>191 (71.9)</td></tr></table> |
e6d242c639a63f4d7e1d0c0d861014cd56317328f7c13ec9e30dbe82640d0e34.png | simple | <table><tr><td>Genotype</td><td>Nr. reads</td><td>Nr. reads after filtration</td><td>Avg. read length bp</td><td>Nr. assembled reads</td><td>Singletons</td><td>Nr. contigs</td><td>Avg. EST length bp</td></tr><tr><td>Connecticut King</td><td>139,480</td><td>104,323(75%)</td><td>336</td><td>77,097(74%)</td><td>27,226(26%)</td><td>14,773</td><td>615</td></tr><tr><td>White Fox</td><td>326,539</td><td>221,597(68%)</td><td>338</td><td>182,393(82%)</td><td>39,204(18%)</td><td>21,898</td><td>663</td></tr><tr><td>Star Gazer</td><td>374,240</td><td>255,081(68%)</td><td>341</td><td>202,707(79.5%)</td><td>52,374(20.5%)</td><td>24,700</td><td>688</td></tr><tr><td>Trumpet</td><td>442,476</td><td>299,655(69%)</td><td>343</td><td>241,782(81%)</td><td>57,873(19%)</td><td>26,075</td><td>694</td></tr><tr><td>Lily-All</td><td>1,282,735</td><td>880,656(69%)</td><td>340</td><td>471,378(53.5%)</td><td>409,278(46.5%)</td><td>52,172</td><td>555</td></tr><tr><td>Cantata</td><td>310,973</td><td>207,229(67%)</td><td>389</td><td>158,007(76%)</td><td>49,222(24%)</td><td>17,646</td><td>625</td></tr><tr><td>Princeps</td><td>316,372</td><td>211,380(67%)</td><td>386</td><td>165,282(78%)</td><td>46,098(22%)</td><td>17,007</td><td>632</td></tr><tr><td><i>T. fosteriana</i></td><td>627,345</td><td>418,609(67%)</td><td>388</td><td>293,043(70%)</td><td>125,566(30%)</td><td>24,713</td><td>629</td></tr><tr><td>Kees Nelis</td><td>592,034</td><td>407,392(69%)</td><td>281</td><td>303,558(74.5%)</td><td>103,834(25.5%)</td><td>38,716</td><td>559</td></tr><tr><td>Ile de France</td><td>263,175</td><td>185,464(70%)</td><td>283</td><td>125,293(67.6%)</td><td>60,171(32%)</td><td>24,557</td><td>517</td></tr><tr><td>Bellona</td><td>221,334</td><td>149,768(67%)</td><td>278</td><td>109,309(34%)</td><td>40,459(27%)</td><td>14,325</td><td>522</td></tr><tr><td><i>T. gesneriana</i></td><td>1,076,543</td><td>742,624(69%)</td><td>281</td><td>536,776 (74%)</td><td>205,848(28%)</td><td>54,575</td><td>557</td></tr><tr><td>Tulip-All</td><td>1,703,888</td><td>1,378,898</td><td>314</td><td>827,772(60%)</td><td>551,126(40%)</td><td>81,791</td><td>514</td></tr></table> |
6506a543ffd6bb3df869e1fa1b254d4503427e8c827722accb6424a972c96748.png | complex | <table><tr><td rowspan="2">Question</td><td colspan="4">Baseline (<i>n</i> = 66)</td><td colspan="4">3 months (<i>n</i> = 54)</td></tr><tr><td>r</td><td>AA</td><td>κ</td><td>ICC</td><td>r</td><td>AA</td><td>κ</td><td>ICC</td></tr><tr><td>1</td><td>0.70</td><td>0.87</td><td>0.70 (0.51 to 0.89)</td><td>0.68 (0.07 to 1.3)</td><td>0.51</td><td>0.87</td><td>0.51 (0.22 to 0.81)</td><td>0.55 (−0.19 to 1.28)</td></tr><tr><td>2</td><td>0.29</td><td>0.86</td><td>0.23 (−0.07 to 0.53)</td><td>0.21 (−0.35 to 0.76)</td><td>−0.09</td><td>0.70</td><td>−0.034 (−0.1 to 0.03)</td><td>−0.03 (−0.08 to 0.02)</td></tr><tr><td>3</td><td>0.30</td><td>0.63</td><td>0.28 (0.06 to 0.49)</td><td>0.14 (−0.26 to 0.54)</td><td>0.25</td><td>0.62</td><td>0.19(−0.02 to 0.4)</td><td>0.15 (−0.36 to 0.66)</td></tr><tr><td>4</td><td>0.42</td><td>0.70</td><td>0.36 (0.15 to 0.56)</td><td>0.28 (−0.33 to 0.88)</td><td>0.08</td><td>0.25</td><td>0.087 (−0.16 to 0.31)</td><td>−0.03 (−0.06 to 0.01)</td></tr><tr><td>5</td><td>0.58</td><td>0.81</td><td>0.50 (0.28 to 0.72)</td><td>0.52 (−0.20 to 1.24)</td><td>0.40</td><td>0.87</td><td>0.39 (0.03 to 0.75)</td><td>0.04 (−0.35 to 1.14)</td></tr><tr><td>6</td><td>0.45</td><td>0.73</td><td>0.45 (0.22 to 0.67)</td><td>0.32 (−0.33 to 0.97)</td><td>0.23</td><td>0.61</td><td>0.22 (−0.03 to 0.48)</td><td>0.06 (−0.20 to 0.33)</td></tr><tr><td>7</td><td>−0.04</td><td>0.91</td><td>−0.03 (−0.07 to 0.02)</td><td>−0.11 (−0.14 to −0.08)</td><td>n/a</td><td>0.96</td><td>n/a</td><td>−0.33 (−0.38 to −0.28)</td></tr><tr><td>8</td><td>0.35</td><td>0.83</td><td>0.28 (−0.001 to 0.57)</td><td>0.51 (−0.28 to 1.30)</td><td>0.24</td><td>0.91</td><td>0.21 (−0.19 to 0.6)</td><td>0.37 (−0.57 to 1.31)</td></tr><tr><td>9</td><td>n/a</td><td>0.92</td><td>n/a</td><td>n/a</td><td>0.86</td><td>0.96</td><td>0.85 (0.66 to 1.1)</td><td>0.91 (0.68 to 1.14)</td></tr><tr><td>10</td><td>0.25</td><td>0.84</td><td>0.21 (−0.18 to 0.61)</td><td>0.22 (−0.42 to 0.87)</td><td>0.28</td><td>0.74</td><td>0.21 (−0.04 to 0.45)</td><td>0.13 (−0.28 to 0.55)</td></tr><tr><td>11</td><td>0.44</td><td>0.77</td><td>0.37 (0.14 to 0.6)</td><td>0.33 (−0.33 to 0.99)</td><td>0.64</td><td>0.83</td><td>0.61 (0.39 to 0.83)</td><td>0.58 (−0.13 to 1.28)</td></tr><tr><td>12</td><td>0.72</td><td>0.86</td><td>0.70 (0.52 to 0.87)</td><td>0.68 (0.05 to 1.30)</td><td>0.78</td><td>0.89</td><td>0.77 (0.61 to 0.94)</td><td>0.76 (0.23 to 1.28)</td></tr><tr><td>13</td><td>0.18</td><td>0.43</td><td>0.06 (−0.01 to 0.13)</td><td>0.03 (−0.14 to 0.20)</td><td>0.13</td><td>0.27</td><td>0.03 (−0.01 to 0.08)</td><td>0.01 (−0.15 to 0.13)</td></tr><tr><td>14</td><td>0.39</td><td>0.69</td><td>0.38 (0.16 to 0.6)</td><td>0.25 (−0.33 to 0.83)</td><td>0.17</td><td>0.60</td><td>0.17 (−0.01 to 0.43)</td><td>0.02 (−0.14 to 0.18)</td></tr></table> |
d57ccd4329e456a0a414666b8a225e0d7bae2726fd055239ed084892b0e35ab0.png | complex | <table><tr><td rowspan="2">Wind Direction</td><td rowspan="2">ASF (ns)</td><td rowspan="2">Error Correction (m)</td><td colspan="4">Statistical Probability of the Error Correction Interval (%)</td><td rowspan="2">Error Correction Average (m)</td></tr><tr><td>0–100 (m)</td><td>100–200 (m)</td><td>200–300 (m)</td><td>300–400 (m)</td></tr><tr><td>East-southeast</td><td>396–727</td><td>118.76–218.21</td><td>0</td><td>96.5</td><td>3.5</td><td>0</td><td>166.9449</td></tr><tr><td>East</td><td>564–868</td><td>169.07–260.33</td><td>0</td><td>23.44</td><td>76.56</td><td>0</td><td>218.6659</td></tr><tr><td>East-northeast</td><td>384–786</td><td>115.25–235.76</td><td>0</td><td>79.22</td><td>20.87</td><td>0</td><td>166.6964</td></tr><tr><td>West</td><td>56.6–376</td><td>16.97–112.91</td><td>99.71</td><td>0.83</td><td>0</td><td>0</td><td>63.7418</td></tr><tr><td>West-northwest</td><td>21.5–400</td><td>6.44–119.9</td><td>96.78</td><td>3.22</td><td>0</td><td>0</td><td>54.8815</td></tr><tr><td>North</td><td>782–1260</td><td>234.58–377.32</td><td>0</td><td>0</td><td>32.33</td><td>67.67</td><td>321.0044</td></tr></table> |
d37607f330ed92d32bd9585415c4487285e767da239b0d8a9680930e7e17fcaa.png | complex | <table><tr><td>Chromosome No.</td><td>Centromere Position</td><td>Relative Length (%)</td><td>Arm Ratio<i><sup>a</sup></i></td><td>45S<i><sup>b</sup></i></td><td>5S<i><sup>b</sup></i></td><td>Satellite<i><sup>b</sup></i></td></tr><tr><td><i>S. oleracea</i> L. Mazeran</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> 1</td><td>Submedian</td><td>19.6</td><td>1.73</td><td></td><td></td><td></td></tr><tr><td> 2</td><td>Submedian</td><td>18.2</td><td>2.17</td><td>S</td><td>L</td><td></td></tr><tr><td> 3</td><td>Subterminal</td><td>17.3</td><td>3.44</td><td></td><td></td><td></td></tr><tr><td> 4</td><td>Subterminal</td><td>16.0</td><td>3.36</td><td></td><td></td><td></td></tr><tr><td> 5</td><td>Subterminal</td><td>14.5</td><td>3.11</td><td>S</td><td>L</td><td>S</td></tr><tr><td> 6</td><td>Subterminal</td><td>14.4</td><td>6.61</td><td>S</td><td></td><td>S</td></tr><tr><td>Total length</td><td></td><td>100</td><td></td><td colspan="3"></td></tr><tr><td><i>S</i>. <i>tetrandra</i> Stev. PI 647859</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> X</td><td>Median</td><td>18.1</td><td>1.29</td><td></td><td></td><td></td></tr><tr><td> Y</td><td>Median</td><td>29.9</td><td>1.12</td><td></td><td></td><td></td></tr><tr><td> 1</td><td>Submedian</td><td>16.7</td><td>2.39</td><td></td><td>L</td><td></td></tr><tr><td> 2</td><td>Submedian</td><td>16.6</td><td>2.84</td><td></td><td></td><td></td></tr><tr><td> 3</td><td>Submedian</td><td>14.8</td><td>1.85</td><td></td><td></td><td></td></tr><tr><td> 4</td><td>Submedian</td><td>17.9</td><td>1.86</td><td>S</td><td>L</td><td>S</td></tr><tr><td> 5</td><td>Submedian</td><td>15.9</td><td>2.46</td><td>S</td><td></td><td>S</td></tr><tr><td>Total length (X)</td><td></td><td>100</td><td></td><td colspan="3"></td></tr><tr><td>Total length (Y)</td><td></td><td>111.8</td><td></td><td colspan="3"></td></tr></table> |
1fa150740142cf82bb1562e13d3aee71719af8ca68097d060e64f80ab5a65875.png | complex | <table><tr><td>Gene</td><td>AT gene locus</td><td>Biological function</td><td>Act./Repr. +/-</td><td>Reference</td><td>Fragaria</td><td>E-value</td></tr><tr><td colspan="7"><i>Autonomous pathway</i></td></tr><tr><td>FCA</td><td>AT4G16280</td><td>RRM-type RNA binding domain containing</td><td>+</td><td>[94]</td><td>nf</td><td></td></tr><tr><td>FPA</td><td>AT2G43410</td><td>RRM-type RNA binding domain containing</td><td>+</td><td>[95]</td><td>nf</td><td></td></tr><tr><td>FLK</td><td>AT3G04610</td><td>KH-type RNA binding domain containing</td><td>+</td><td>[96]</td><td>EX668302</td><td>5E-52</td></tr><tr><td>FY</td><td>AT5G13480</td><td>mRNA 3' end processing factor</td><td>+</td><td>[97]</td><td>EX659635</td><td>5E-75</td></tr><tr><td>SKB1</td><td>AT4G31120</td><td>Arginine methyltransferase</td><td>+</td><td>[98]</td><td>nf</td><td></td></tr><tr><td>FVE</td><td>AT2G19520</td><td>retinoblastoma associated</td><td>+</td><td>[24]</td><td>VES-001-B03</td><td>3E-76</td></tr><tr><td>LD</td><td>AT4G02560</td><td>DNA/RNA binding homeodomain protein</td><td>+</td><td>[99]</td><td>DY670534</td><td>3E-49</td></tr><tr><td>FLD</td><td>AT3G10390</td><td>component of histone deacetylase complex</td><td>+</td><td>[23]</td><td>nf</td><td></td></tr><tr><td>LDL1/SWP1</td><td>AT1G62830</td><td>Histone H3-Lys 4 demetylase-like</td><td>+</td><td>[22]</td><td>Contig 2573</td><td>2E-27</td></tr><tr><td>LDL2</td><td>AT3G13682</td><td>Histone H3-Lys 4 demetylase-like</td><td>+</td><td>[22]</td><td>DY669828</td><td>1E-42</td></tr><tr><td colspan="7"><i>Gibberellin pathway</i></td></tr><tr><td>GAI</td><td>AT1G14920</td><td>putative transcriptional repressor</td><td>-</td><td>[100]</td><td>Contig 3276</td><td>3E-147</td></tr><tr><td>RGA</td><td>AT2G01570</td><td>putative transcriptional repressor</td><td>-</td><td>[100]</td><td>DQ195503</td><td>8E-60</td></tr><tr><td>SPY</td><td>AT3G11540</td><td>O-linked N-acetylglucosamine transferase</td><td>-</td><td>[101]</td><td>BAR-002-C02</td><td>2E-93</td></tr><tr><td>DDF1</td><td>AT1G12610</td><td>AP2-like TF</td><td>+</td><td>[102]</td><td>Contig 3158</td><td>5E-49</td></tr><tr><td>DDF2</td><td>AT1G63030</td><td>AP2-like TF</td><td>+</td><td>[102]</td><td>nf</td><td></td></tr><tr><td>AtMYB33</td><td>AT5G06100</td><td>MYB TF</td><td>+</td><td>[25]</td><td>DY669997</td><td>5E-29</td></tr><tr><td>FPF1</td><td>AT5G24860</td><td>Unknown</td><td>+</td><td>[103]</td><td>Contig 4074</td><td>7E-38</td></tr><tr><td colspan="7"><i>Other</i></td></tr><tr><td>SVP</td><td>AT2G22540</td><td>MADS-box TF</td><td>-</td><td>[57]</td><td>VES-013-D05</td><td>5E-22</td></tr><tr><td>AP2</td><td>AT4G36920</td><td>AP2 TF</td><td>-</td><td>[104]</td><td>VES-008-A07</td><td>9E-16</td></tr><tr><td>PFT1</td><td>AT1G25540</td><td>vWF-A domain protein</td><td>+</td><td>[48]</td><td>BAR-002-D08</td><td>1E-17</td></tr><tr><td>HRB1</td><td>AT5G49230</td><td>ZZ type zinc finger protein</td><td>+</td><td>[49]</td><td>VES-012-B01</td><td>7E-22</td></tr></table> |
94deeebe294ffde7a8c8bf179e4ac728c989ad5c031fbfe980d9bf6e1beab05d.png | complex | <table><tr><td rowspan="2">Protein</td><td colspan="4">Network centrality scores</td><td rowspan="2">PDB</td></tr><tr><td>Betweenness</td><td>Eigenvector</td><td>Degree</td><td>Closeness</td></tr><tr><td>Rv3019c</td><td>71224.33</td><td>0.08889492</td><td>167</td><td>0.0488181</td><td>3H6P </td></tr><tr><td>Rv0451c</td><td>66230.336</td><td>0.09615834</td><td>171</td><td>0.0488344</td><td>2LW3 </td></tr><tr><td>Rv0288</td><td>63475.453</td><td>0.09102694</td><td>170</td><td>0.0488555</td><td>2KG7 </td></tr><tr><td>Rv0058</td><td>57680.18</td><td>0.00275039</td><td>62</td><td>0.0481486</td><td>2R5U </td></tr><tr><td>Rv1908c</td><td>50548.035</td><td>0.00563762</td><td>76</td><td>0.0484564</td><td>1SFZ; 1SJ2; 2CCA; 2CCD; 4C50; 4C51 </td></tr><tr><td>Rv2050</td><td>40088.305</td><td>0.01941196</td><td>91</td><td>0.0485105</td><td>2M4V; 2M6P </td></tr><tr><td>Rv2150c</td><td>37525.4</td><td>0.00763293</td><td>103</td><td>0.0484339</td><td>1RLU; 1RQ2; 1RQ7; 2Q1X; 2Q1Y; 4KWE </td></tr><tr><td>Rv3793</td><td>36733.14</td><td>0.06872068</td><td>136</td><td>0.0487904</td><td>3PTY </td></tr><tr><td>Rv2111c</td><td>35411.24</td><td>0.00444417</td><td>37</td><td>0.0479427</td><td>3M91; 3M9D </td></tr><tr><td>Rv0002</td><td>33375.504</td><td>0.00362037</td><td>90</td><td>0.0482796</td><td>3P16; 3RB9 </td></tr><tr><td>Rv3597c</td><td>27758.719</td><td>0.01894281</td><td>73</td><td>0.048406</td><td>2KNG; 4E1P; 4E1R </td></tr><tr><td>Rv1837c</td><td>24302.383</td><td>0.00201247</td><td>47</td><td>0.0479375</td><td>2GQ3; 3S9I; 3S9Z; 3SAD; 3SAZ; 3SB0 </td></tr><tr><td>Rv0467</td><td>23928.854</td><td>0.00293969</td><td>53</td><td>0.0481574</td><td>1F61; 1F8I; 1F8M </td></tr><tr><td>Rv3240c</td><td>22790.56</td><td>0.00369075</td><td>64</td><td>0.0481586</td><td>1NKT; 1NL3 </td></tr><tr><td>Rv0216</td><td>20616.273</td><td>0.01939864</td><td>57</td><td>0.0482126</td><td>2BI0 </td></tr><tr><td>Rv1611</td><td>17798.758</td><td>0.00289133</td><td>57</td><td>0.0481961</td><td>3QJA; 3T40; 3T44; 3T55; 3T78; 4FB7 </td></tr><tr><td>Rv2773c</td><td>17351.877</td><td>0.00189925</td><td>52</td><td>0.0480259</td><td>1C3V; 1P9L; 1YL5; 1YL6; 1YL7 </td></tr><tr><td>Rv0902c</td><td>16640.244</td><td>0.02111599</td><td>42</td><td>0.0480668</td><td>1YS3; 1YSR </td></tr><tr><td>Rv2711</td><td>15661.199</td><td>0.00590289</td><td>41</td><td>0.0481721</td><td>1B1B; 1FX7; 1U8R; 2ISY; 2ISZ; 2IT0 </td></tr><tr><td>Rv3601c</td><td>15341.172</td><td>0.00251573</td><td>49</td><td>0.0481235</td><td>2C45 </td></tr><tr><td>Rv2518c</td><td>14995.93</td><td>0.00281853</td><td>25</td><td>0.0477322</td><td>3VYN; 3VYO; 3VYP; 4GSQ; 4GSR; 4GSU; 4HU2; 4HUC </td></tr><tr><td>Rv0736</td><td>14264.871</td><td>0.01536277</td><td>50</td><td>0.0483009</td><td>3HUG </td></tr><tr><td>Rv2538c</td><td>14206.7705</td><td>0.00232458</td><td>65</td><td>0.0481065</td><td>3QBD; 3QBE </td></tr><tr><td>Rv3808c</td><td>13873.782</td><td>0.00814938</td><td>51</td><td>0.0480131</td><td>4FIX; 4FIY </td></tr><tr><td>Rv2416c</td><td>13419.646</td><td>0.00771849</td><td>39</td><td>0.0482891</td><td>3R1K; 3RYO; 3SXO; 3UY5 </td></tr><tr><td>Rv2987c</td><td>13133.913</td><td>0.0017555</td><td>52</td><td>0.0479834</td><td>3H5E; 3H5H; 3H5J </td></tr><tr><td>Rv2986c</td><td>13109.861</td><td>0.00315177</td><td>40</td><td>0.0481223</td><td>4DKY; 4PT4 </td></tr><tr><td>Rv2391</td><td>12401.702</td><td>0.00120635</td><td>45</td><td>0.0478749</td><td>1ZJ8; 1ZJ9 </td></tr></table> |
8f733362e5596d0e00f92fdb6456a6a452185dc700ac5dc658d5819749358c02.png | simple | <table><tr><td>Variable</td><td>Description (N = 10)</td></tr><tr><td>Age (years old)</td><td></td></tr><tr><td>Mean (St. Dev.)</td><td>2.57 (0.99) </td></tr><tr><td>Median (min / max) </td><td>2.21 (2; 5)</td></tr><tr><td>Age range, n (%)</td><td></td></tr><tr><td>< 3 years old</td><td>8 (80.0) </td></tr><tr><td>≥ 3 years old</td><td>2 (20.0)</td></tr><tr><td>Gender, n (%) </td><td></td></tr><tr><td>Feminine</td><td>4 (40.0)</td></tr><tr><td>Masculine</td><td>6 (60.0)</td></tr><tr><td>Laterality, n (%)</td><td></td></tr><tr><td>Unilateral</td><td>5 (50.0) </td></tr><tr><td>Bilateral</td><td>5 (50.0)</td></tr></table> |
79d41596a9ea4e47bbf837df18ebe473dca3360db7cfc5c11b66da43398ce614.png | complex | <table><tr><td>Variables</td><td>Frequency</td><td>Percentage</td></tr><tr><td colspan="3">Malaria vaccine will prevent malaria</td></tr><tr><td> Indifferent</td><td>40</td><td>8.0</td></tr><tr><td> Agree</td><td>159</td><td>31.8</td></tr><tr><td> Strongly agree</td><td>301</td><td>60.2</td></tr><tr><td colspan="3">Everyone should receive malaria vaccine</td></tr><tr><td> Disagree</td><td>15</td><td>3.0</td></tr><tr><td> Indifferent</td><td>75</td><td>15.0</td></tr><tr><td> Agree</td><td>103</td><td>20.6</td></tr><tr><td> Strongly agree</td><td>307</td><td>61.4</td></tr><tr><td colspan="3">I will take the malaria vaccine when produced</td></tr><tr><td> Indifferent</td><td>30</td><td>6.0</td></tr><tr><td> Agree</td><td>70</td><td>14.0</td></tr><tr><td> Strongly agree</td><td>400</td><td>80.0</td></tr><tr><td colspan="3">Malaria vaccine is not against our cultural belief</td></tr><tr><td> Indifferent</td><td>35</td><td>7.0</td></tr><tr><td> Agree</td><td>32</td><td>6.4</td></tr><tr><td> Strongly agree</td><td>433</td><td>86.6</td></tr><tr><td colspan="3">Malaria is a major health problem requiring vaccine</td></tr><tr><td> Disagree</td><td>30</td><td>6.0</td></tr><tr><td> Agree</td><td>167</td><td>33.4</td></tr><tr><td> Strongly agree</td><td>303</td><td>60.6</td></tr><tr><td colspan="3">Malaria vaccine will save money spent on treatment</td></tr><tr><td> Disagree</td><td>23</td><td>4.6</td></tr><tr><td> Indifferent</td><td>67</td><td>13.4</td></tr><tr><td> Agree</td><td>129</td><td>25.8</td></tr><tr><td> Strongly agree</td><td>281</td><td>56.2</td></tr><tr><td colspan="3">Malaria vaccine will not have adverse health effect</td></tr><tr><td> Strong degree</td><td>61</td><td>12.2</td></tr><tr><td> Disagree</td><td>109</td><td>21.8</td></tr><tr><td> Indifferent</td><td>20</td><td>4.0</td></tr><tr><td> Agree</td><td>101</td><td>20.2</td></tr><tr><td> Strongly agree</td><td>209</td><td>41.8</td></tr><tr><td colspan="3">Malaria vaccine will save man hour lost to malaria</td></tr><tr><td> Agree</td><td>199</td><td>39.8</td></tr><tr><td> Strongly agree</td><td>301</td><td>60.2</td></tr></table> |
57f1dc137aa7ac8ba680cbdaaa3c49c6491e1805a8d77b9898f0c223e53223b5.png | complex | <table><tr><td>Variable</td><td>Normotensive Non pregnant women n (75)</td><td>Normotensive pregnant women n (102)</td><td>Pre-eclamptic women n (100)</td><td>Total N (277)</td></tr><tr><td colspan="5">Age (years)</td></tr><tr><td><20</td><td>1 (1.3)</td><td>5 (4.9)</td><td>2 (2.0)</td><td>8 (2.9)</td></tr><tr><td>20–34</td><td>51 (68.0)</td><td>85 (83.3)</td><td>69 (69.0)</td><td>205 (74.0)</td></tr><tr><td>≥35</td><td>23 (30.7)</td><td>12 (11.8)</td><td>29 (29.0)</td><td>64 (23.1)</td></tr><tr><td colspan="5">Parity</td></tr><tr><td>0</td><td>38 (50.7)</td><td>35 (34.3)</td><td>61 (61.0)</td><td>134 (48.4)</td></tr><tr><td>1</td><td>21 (28.0)</td><td>34 (33.3)</td><td>20 (20.0)</td><td>75 (27.1)</td></tr><tr><td>2≥</td><td>16 (21.3)</td><td>33 (32.4)</td><td>19 (19.0)</td><td>68 (24.5)</td></tr><tr><td colspan="5">GA at delivery</td></tr><tr><td><34</td><td>-</td><td>3 (0.3)</td><td>10 (10.0)</td><td>13 (6.4)</td></tr><tr><td>34–36</td><td>-</td><td>5 (0.5)</td><td>44 (44.0)</td><td>49 (24.3)</td></tr><tr><td>≥37</td><td>-</td><td>94 (92.2)</td><td>46 (46.0)</td><td>140 (69.3)</td></tr></table> |
6da7a6d20f0cf40e228b84b19c23380bff124838757439a3cee23d110aa6c7f7.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="4">Blood flow =1,500mL/min</td><td colspan="3">Blood flow =3,500mL/min</td><td rowspan="2">p value*</td></tr><tr><td>Sweep flow 3.0L/min</td><td>Sweep flow 1.5L/min</td><td>Sweep flow 10L/min</td><td>Sweep flow 2.0L/min</td><td>Sweep flow 3.5L/min</td><td>Sweep flow 7.0L/min</td><td>Sweep flow 12L/min</td></tr><tr><td>Cardiac output (L/min)</td><td>6.5 [6.4, 6.9]</td><td>6.3 [4.0, 6.7]</td><td>7.7 [3.6, 9.4]</td><td>7.3 [4.3, 9.3]</td><td>9.0 [4.4, 9.1]</td><td>7.6 [4.8, 8.2]</td><td>6.3 [4.8, 7.9]</td><td>0.834</td></tr><tr><td>Heart rate (bpm)</td><td>134 [124, 145]</td><td>133 [95, 137]</td><td>135 [123, 147]</td><td>128 [124, 149]</td><td>137 [131, 160]</td><td>121 [121, 153]</td><td>128 [123, 161]</td><td>0.867</td></tr><tr><td>ABPm (mmHg)</td><td>126 [106, 126]</td><td>106 [100,125]</td><td>101 [91, 112]</td><td>98 [92, 105]</td><td>103 [94, 114]</td><td>113 [112, 122]</td><td>122 [119, 123]</td><td>0.154</td></tr><tr><td>PAPm (mmHg)</td><td>54 [41, 59]</td><td>46 [42, 47]</td><td>36 [32, 46]</td><td>47 [34, 48]</td><td>40 [31, 47]</td><td>42 [35, 45]</td><td>39 [33, 44]</td><td>0.248</td></tr><tr><td>CVP (mmHg)</td><td>6 [5, 13]</td><td>6 [4, 16]</td><td>5 [4, 13]</td><td>5 [3, 15]</td><td>5 [4, 14]</td><td>5 [4, 11]</td><td>5 [4, 11]</td><td>0.299</td></tr><tr><td>PAOP (mmHg)</td><td>11 [10, 12]</td><td>8 [8, 11]</td><td>8 [7, 11]</td><td>7 [5, 9]</td><td>8 [7, 8]</td><td>8 [6, 16]</td><td>8 [7, 17]</td><td>0.715</td></tr></table> |
90852fe3675d7de8e0f92db0d3f1614502be80dccd9e0f2592958537ec0ecc5b.png | complex | <table><tr><td rowspan="2">Characteristic</td><td colspan="3">HBC</td><td rowspan="2">SBC</td></tr><tr><td>HBOC</td><td>HBCC</td><td>Other*</td></tr><tr><td>Number of patients, n (%)</td><td>77 (74.8)</td><td>4 (3.9)</td><td>22 (21.4)</td><td>101 (100)</td></tr><tr><td>Age at diagnosis, mean (sd)</td><td>45.75 (11.8)</td><td>47.66 (3.2)</td><td>41.1 (10.4)</td><td>56.9 (5.2)</td></tr><tr><td>Age at diagnosis >50, n (%)</td><td>25 (32.5)</td><td>0</td><td>6 (27.3)</td><td>101 (100)</td></tr><tr><td>Bilateral breast cancer, n (%)</td><td>50 (74.6)</td><td>3 (4.5)</td><td>5 (7.5)</td><td>9 (13.4)</td></tr><tr><td>Synchronic</td><td>23 (47.8)</td><td>2 (66.7)</td><td>-</td><td>2 (22.2)</td></tr><tr><td>Metachronic</td><td>26 (50.0)</td><td>0</td><td>-</td><td>7 (77.8)</td></tr><tr><td>Missing</td><td>1 (2.2)</td><td>1 (33.3)</td><td>5 (100)</td><td>0</td></tr></table> |
8b39ee559da42341102f99f2ca7dba9b15fd33779d4d48a1c3d527740b9f0da4.png | complex | <table><tr><td></td><td colspan="2">Unaffected (n = 865)</td><td colspan="2">Slightly affected (n = 1408)</td><td>OR<sup>1</sup></td><td>95% CI<sup>1</sup></td><td>p</td><td colspan="2">Seriously affected (n = 427)</td><td>OR<sup>2</sup></td><td>95% CI<sup>2</sup></td><td>p</td></tr><tr><td></td><td>N</td><td>%</td><td>N</td><td>%</td><td></td><td></td><td></td><td>N</td><td>%</td><td></td><td></td><td></td></tr><tr><td>SF-36</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Physical functioning</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>S.W.S.S.<sup>3</sup></td><td>220</td><td>25.70</td><td>299</td><td>21.37</td><td>0.99</td><td>0.77 – 1.26</td><td>0.909</td><td>73</td><td>17.26</td><td>0.93</td><td>0.63 – 1.38</td><td>0.073</td></tr><tr><td> Role-physical</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>S.W.S.S.<sup>3</sup></td><td>122</td><td>14.25</td><td>180</td><td>12.87</td><td>0.92</td><td>0.69 – 1.22</td><td>0.562</td><td>53</td><td>12.53</td><td>0.93</td><td>0.61 – 1.44</td><td>0.774</td></tr><tr><td> Bodily pain</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>S.W.S.S.<sup>3</sup></td><td>320</td><td>37.38</td><td>559</td><td>39.96</td><td>1.29</td><td>1.05 – 1.57</td><td>0.013</td><td>154</td><td>36.41</td><td>1.29</td><td>0.95 – 1.74</td><td>0.098</td></tr><tr><td> General health</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>S.W.S.S.<sup>3</sup></td><td>260</td><td>30.37</td><td>414</td><td>25.59</td><td>1.00</td><td>0.80 – 1.25</td><td>0.986</td><td>129</td><td>30.50</td><td>0.96</td><td>0.69 – 1.32</td><td>0.789</td></tr><tr><td> Vitality</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>S.W.S.S.<sup>3</sup></td><td>121</td><td>14.14</td><td>173</td><td>12.37</td><td>0.88</td><td>0.65 – 1.18</td><td>0.388</td><td>46</td><td>10.87</td><td>0.92</td><td>0.59 – 1.45</td><td>0.725</td></tr><tr><td> Social functioning</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>S.W.S.S.<sup>3</sup></td><td>189</td><td>22.08</td><td>273</td><td>19.51</td><td>0.79</td><td>0.62 – 1.00</td><td>0.055</td><td>76</td><td>17.97</td><td>0.74</td><td>0.51 – 1.06</td><td>0.104</td></tr><tr><td> Role-emotional</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>S.W.S.S.<sup>3</sup></td><td>68</td><td>7.94</td><td>104</td><td>7.43</td><td>0.86</td><td>0.59 – 1.23</td><td>0.408</td><td>30</td><td>7.09</td><td>0.80</td><td>0.46 – 1.38</td><td>0.417</td></tr><tr><td> Mental health</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>S.W.S.S.<sup>3</sup></td><td>180</td><td>21.30</td><td>330</td><td>23.59</td><td>1.06</td><td>0.83 – 1.35</td><td>0.631</td><td>96</td><td>22.70</td><td>1.00</td><td>0.70 – 1.43</td><td>0.993</td></tr><tr><td>GHQ-28</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Somatic Symptoms</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cases</td><td>27</td><td>3.12</td><td>29</td><td>2.07</td><td>0.60</td><td>0.34 – 1.09</td><td>0.093</td><td>9</td><td>2.12</td><td>0.61</td><td>0.25 – 1.47</td><td>0.268</td></tr><tr><td> Anxiety and insomnia</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cases</td><td>20</td><td>2.31</td><td>40</td><td>2.85</td><td>0.10</td><td>0.60 – 2.01</td><td>0.762</td><td>14</td><td>3.29</td><td>1.36</td><td>0.59 – 3.16</td><td>0.472</td></tr><tr><td> Severe depression</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cases</td><td>2</td><td>0.23</td><td>5</td><td>0.36</td><td>1.35</td><td>0.21 – 8.55</td><td>0.752</td><td>1</td><td>0.24</td><td>1.05</td><td>0.06 – 18.96</td><td>0.973</td></tr><tr><td> Social dysfunction</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cases</td><td>11</td><td>1.27</td><td>18</td><td>1.28</td><td>0.87</td><td>0.37 – 2.07</td><td>0.755</td><td>4</td><td>0.94</td><td>0.59</td><td>0.16 – 2.21</td><td>0.432</td></tr><tr><td>HADS</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Anxiety</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cases (prob+conf)*</td><td>87</td><td>10.06</td><td>150</td><td>10.65</td><td>1.04</td><td>0.76 – 1.44</td><td>0.786</td><td>44</td><td>10.3</td><td>1.14</td><td>0.71 – 1.86</td><td>0.576</td></tr><tr><td>Cases (conf)**</td><td>39</td><td>4.51</td><td>59</td><td>4.19</td><td>0.85</td><td>0.53 1.36</td><td>0.496</td><td>18</td><td>4.22</td><td>0.81</td><td>0.39 – 1.67</td><td>0.572</td></tr><tr><td> Depression</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cases (prob+conf)*</td><td>33</td><td>3.82</td><td>40</td><td>2.84</td><td>0.67</td><td>0.38 – 1.16</td><td>0.150</td><td>9</td><td>2.11</td><td>0.57</td><td>0.21 – 1.33</td><td>0.176</td></tr><tr><td>Cases (conf)*</td><td>10</td><td>1.16</td><td>11</td><td>0.78</td><td>0.86</td><td>0.32 – 2.32</td><td>0.771</td><td>4</td><td>0.94</td><td>1.60</td><td>0.38 – 6.78</td><td>0.527</td></tr><tr><td>GADS</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Anxiety</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cases</td><td>112</td><td>12.95</td><td>179</td><td>12.71</td><td>0.92</td><td>0.69 – 1.24</td><td>0.602</td><td>49</td><td>11.48</td><td>0.88</td><td>0.56 – 1.38</td><td>0.582</td></tr><tr><td> Depression</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cases</td><td>75</td><td>8.67</td><td>110</td><td>7.81</td><td>0.71</td><td>0.48 – 1.03</td><td>0.071</td><td>26</td><td>6.09</td><td>0.47</td><td>0.26 – 0.85</td><td>0.012</td></tr></table> |
d666519c8667648ad6d747406df134c613b2d707aa763f32b4e8fdbe4935b716.png | simple | <table><tr><td>Function Name</td><td>Operations Number/Pixel</td></tr><tr><td>“format”</td><td>10</td></tr><tr><td>“format_bis”</td><td>14</td></tr><tr><td>“sobel”</td><td>15</td></tr><tr><td>“prewitt”</td><td>14</td></tr><tr><td>“matrix”</td><td>8</td></tr><tr><td>“filter”</td><td>10 × 3</td></tr><tr><td>“filtre_gauss”</td><td>(12 + 6 × (filter size)) × 3</td></tr><tr><td>“critere_Harris”</td><td>10</td></tr><tr><td>“critere_Shi”</td><td>31</td></tr><tr><td>“look_for_max”</td><td>6</td></tr></table> |
1d412a2606e1b2a1b8b8a584f97d02b35f83860df2f980c01da4bdacd599b61d.png | complex | <table><tr><td rowspan="2">Reference</td><td rowspan="2">Country</td><td rowspan="2">Number ofpatients with BP</td><td rowspan="2">Goldstandard</td><td colspan="2">BP180</td><td colspan="2">BP230</td></tr><tr><td>Sensitivity</td><td>Specificity</td><td>Sensitivity</td><td>Specificity</td></tr><tr><td>Tampoia<i>et al.</i><sup>20</sup></td><td>Italy</td><td>36</td><td>ELISA</td><td>85%</td><td>100%</td><td>44%</td><td>100%</td></tr><tr><td>van Beek<i>et al.</i><sup>18</sup></td><td>Germany</td><td>42</td><td>ELISA</td><td>100%</td><td>98%</td><td>55%</td><td>100%</td></tr><tr><td>Zarian<i>et al.</i><sup>19</sup></td><td>Italy</td><td>18</td><td>ELISA</td><td>83%</td><td>100%</td><td>39%</td><td>100%</td></tr><tr><td>Chiang<i>et al.</i>*<sup>17</sup></td><td>Australia</td><td>18</td><td>ELISA</td><td>77%</td><td>84%</td><td>94%</td><td>63%</td></tr></table> |
1580df8238ded2d825db1a70b9d46b59cb51e7dadefc1b48b8d6e63a639e759d.png | complex | <table><tr><td></td><td colspan="6">"IUI + IVF" for those failing IUI</td></tr><tr><td>IUI modality</td><td>One cycle of IUI</td><td>Two cycles of IUI</td><td>Three cycles of IUI</td><td>Four cycles of IUI</td><td>Five cycles of IUI</td><td>Six cycles of IUI</td></tr><tr><td>U-IUI (LBR = 3.5%)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cost difference "IUI+IVF" vs. primary IVF</td><td>£2,600</td><td>£36,100</td><td>£70,100</td><td>£104,400</td><td>£139,100</td><td>£174,200</td></tr><tr><td>N<sup>o </sup>of IVF cycles that would be purchased by the cost difference</td><td>1</td><td>11</td><td>22</td><td>32</td><td>43</td><td>54</td></tr><tr><td>N<sup>o </sup>of live birth-producing pregnancies expected from IVF cycles that would have been purchased by the cost difference</td><td>0</td><td>4</td><td>6</td><td>8</td><td>11</td><td>14</td></tr><tr><td>S-IUI (LBR = 7%)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cost difference "IUI+IVF" vs. primary IVF</td><td>£48,100</td><td>£122,600</td><td>£199,100</td><td>£277,200</td><td>£356,900</td><td>£438,000</td></tr><tr><td>N<sup>o </sup>of IVF cycles that would be purchased by the cost difference</td><td>15</td><td>38</td><td>62</td><td>86</td><td>111</td><td>136</td></tr><tr><td>N<sup>o </sup>of live birth-producing pregnancies expected from IVF cycles that would have been purchased by the cost difference</td><td>4</td><td>10</td><td>16</td><td>22</td><td>28</td><td>35</td></tr><tr><td>C-IUI (LBR = 3%)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cost difference "IUI+IVF" vs. primary IVF</td><td>£34,300</td><td>£98,900</td><td>£163,400</td><td>£228,000</td><td>£292,600</td><td>£357,200</td></tr><tr><td>N<sup>o </sup>of IVF cycles that would be purchased by the cost difference</td><td>11</td><td>31</td><td>51</td><td>71</td><td>91</td><td>111</td></tr><tr><td>N<sup>o </sup>of live birth-producing pregnancies expected from IVF cycles that would have been purchased by the cost difference</td><td>3</td><td>8</td><td>13</td><td>18</td><td>23</td><td>28</td></tr></table> |
f03cfbc0908d99afa68de12f49d24519727bbd41bff8d79cd4a1434d8cac2758.png | simple | <table><tr><td>Outcome</td><td>Index group n/N (%)</td><td>Control group A, n/N (%)</td><td>Crude OR (95 % CI)</td><td>Adjusted OR (95 % CI)</td></tr><tr><td>Normal delivery</td><td>21/76 (27.6 %)***</td><td>90/150 (60 %)</td><td>0.26 (0.14–0.50)*</td><td>0.30 (0.15–0.60)**</td></tr><tr><td>Instrumental delivery<sup>a</sup></td><td>13/58 (22.4 %)</td><td>20/142 (14.1 %)</td><td>1.77 (0.74–4.25)</td><td>1.95 (0.75–5.09)</td></tr><tr><td>Caesarean Section (CS)</td><td>42/76 (55.3 %)***</td><td>39/150 (26 %)</td><td>3.69 (1.97–6.92)***</td><td>2.95 (1.52–5.71)**</td></tr><tr><td>Non emergency CS</td><td>18/76 (23.7 %)***</td><td>8/150 (5.3 %)</td><td>5.79 (2.36–14.22)***</td><td>5.13 (2.00–13.17)**</td></tr><tr><td>Emergency CS<sup>a</sup></td><td>24/58(41.4 %)**</td><td>31/142(21.8 %)</td><td>2.49(1.20–5.13)**</td><td>1.93(0.88–4.22)</td></tr><tr><td>Induction of labor<sup>a</sup></td><td>33/58 (56.9 %)***</td><td>31/142 (21.8 %)</td><td>3.34 (1.63–6.82)***</td><td>3.00 (1.39–6.44)**</td></tr><tr><td>Uterine Inertia, primary-secondary<sup>a</sup></td><td>13/58 (22.4 %)</td><td>32/142 (22.5 %)</td><td>0.82 (0.36–1.84)</td><td>0.88 (0.36–2.16)</td></tr><tr><td>Hypertensive disorders of pregnancy<sup>f</sup></td><td>12/76 (15.8 %)*</td><td>9/150 (6 %)</td><td>3.42 (1.32–8.86)*</td><td>2.84 (1.04–7.81)*</td></tr><tr><td>Pregnancy-Induced Hypertension</td><td>2/76 (2.6 %)</td><td>0/150</td><td>–</td><td>–</td></tr><tr><td>Preeclampsia</td><td>10/76 (13.2 %)</td><td>9/150 (6 %)</td><td>2.37 (0.92–6.12)</td><td>2.41 (0.84–6.89)</td></tr><tr><td>Fetal distress<sup>a</sup></td><td>16/58 (27.6 %)*</td><td>21/142 (14.8 %)</td><td>2.62 (1.11–6.19)*</td><td>1.96 (0.78–4.97)</td></tr><tr><td>Very Preterm birth (<32 weeks)</td><td>3/76 (3.9 %)</td><td>3/150 (2.0 %)</td><td>6.19 (0.63–60.76)</td><td>6.48 (0.61–68.56)<sup>b</sup></td></tr><tr><td>Preterm birth (<37 weeks)</td><td>13/76 (17.1 %)</td><td>13/150 (8.7 %)</td><td>2.42 (0.97–6.05)</td><td>1.86 (0.70–4.95)<sup>b</sup></td></tr><tr><td>Maternal Hospitalization post partum</td><td></td><td></td><td></td><td></td></tr><tr><td><i>≥</i>2 days</td><td>73/75(97.3 %)**</td><td>127/148 (85.8 %)</td><td>10.40 (1.36–79.80)*</td><td>4.47 (0.53–37.76)<sup>c</sup></td></tr><tr><td><i>≥</i>3 days</td><td>59/75(78.7 %)**</td><td>86/148 (58.1 %)</td><td>2.64 (1.33–5.26)**</td><td>1.14 (0.51–2.58)<sup>c</sup></td></tr><tr><td>Post-partum hemorrhage</td><td>12/76 (15.8 %)**</td><td>7/150 (4.7 %)</td><td>3.29 (1.12–9.70)**</td><td>7.11(2.02–24.97)<sup>d</sup>**</td></tr><tr><td>Retained placenta<sup>e</sup></td><td>8/34 (23.5 %)**</td><td>4/111 (3.6 %)</td><td>7.58 (2.03–28.30)**</td><td>6.71 (1.58–28.40)*</td></tr></table> |
9a4877348c007adfbc3d026da81e291c68ed444d39380e5fab7e109a65f91da5.png | simple | <table><tr><td>Variable</td><td>Principal Component 1 Loadings</td><td>Principal Component 2 Loadings</td></tr><tr><td>pH</td><td>−0.998</td><td></td></tr><tr><td>Total dissolved solids</td><td>−0.992</td><td></td></tr><tr><td>Electrical Conductivity</td><td>−0.962</td><td></td></tr><tr><td>Caffeine</td><td>0.980</td><td></td></tr><tr><td>Carbamazepine</td><td>0.935</td><td></td></tr><tr><td>Tonalide</td><td></td><td>0.997</td></tr><tr><td>Galaxolide</td><td></td><td>0.961</td></tr><tr><td>Bisphenol A</td><td>0.906</td><td></td></tr><tr><td>Nonylphenol</td><td></td><td>0.902</td></tr><tr><td>% Variance</td><td>51.46</td><td>38.53</td></tr><tr><td>Cumulative %</td><td>51.46</td><td>89.99</td></tr></table> |
66e5fa2a3a0d83e18f4c553f7431ad10138ee0e1b4a6a692ad23bc46ee3e56b1.png | complex | <table><tr><td colspan="7">Arbitrary speed zones</td></tr><tr><td> </td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td></tr><tr><td>MDL-1</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Times (s)</td><td>20 ± 86*</td><td>6 ± 101</td><td>−107 ± 74*</td><td>94 ± 54*</td><td>1 ± 70</td><td>3 ± 49</td></tr><tr><td> Distances (m)</td><td>−27 ± 24*</td><td>21 ± 78*</td><td>−124 ± 84*</td><td>160 ± 86*</td><td>0 ± 167</td><td>0 ± 117</td></tr><tr><td>MDL-5</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Times (s)</td><td>−24 ± 77*</td><td>−48 ± 116*</td><td>55 ± 114*</td><td>53 ± 122*</td><td>3 ± 78</td><td>−22 ± 50*</td></tr><tr><td> Distances (m)</td><td>−22 ± 24*</td><td>−29 ± 89*</td><td>81 ± 135*</td><td>113 ± 132*</td><td>7 ± 152</td><td>−68 ± 130*</td></tr></table> |
f3b0b3c68db9f71dbc32f53f26a79d839410bb1260a75a685d843d45e45e1781.png | complex | <table><tr><td>Irrelevant feature NO.</td><td colspan="5">Cost time(s)</td></tr><tr><td></td><td>LHDA</td><td>LDPP</td><td>LSDA</td><td>LM-NNDA</td><td>I-Relief</td></tr><tr><td>100</td><td>18.82</td><td>2.09</td><td>0.05</td><td>57.86</td><td>3.23</td></tr><tr><td>200</td><td>40.24</td><td>2.63</td><td>0.07</td><td>134.36</td><td>7.72</td></tr><tr><td>300</td><td>87.96</td><td>3.00</td><td>0.11</td><td>632.91</td><td>11.83</td></tr><tr><td>400</td><td>139.13</td><td>3.31</td><td>0.25</td><td>487.89</td><td>30.71</td></tr><tr><td>500</td><td>203.28</td><td>3.60</td><td>0.24</td><td>493.70</td><td>35.03</td></tr><tr><td>600</td><td>285.81</td><td>3.58</td><td>0.35</td><td>560.68</td><td>61.91</td></tr><tr><td>700</td><td>366.59</td><td>5.45</td><td>0.34</td><td>651.41</td><td>73.77</td></tr><tr><td>800</td><td>505.73</td><td>6.05</td><td>0.32</td><td>758.55</td><td>83.78</td></tr><tr><td>900</td><td>655.34</td><td>6.58</td><td>0.39</td><td>972.84</td><td>95.71</td></tr><tr><td>1000</td><td>699.42</td><td>7.11</td><td>0.35</td><td>1201.89</td><td>108.58</td></tr></table> |
b718a317c2d3c04e66bd86bd8c5bef87dc80550cd4c4067337fb8223da193a84.png | complex | <table><tr><td></td><td colspan="2">Adolescents with type 1 diabetes</td><td colspan="2">U.S. National Norm</td></tr><tr><td></td><td>%</td><td><i>n</i></td><td>%</td><td><i>P</i><i>-</i>value</td></tr><tr><td>How would you rate the health of your teeth?*</td><td></td><td></td><td></td><td></td></tr><tr><td> Excellent/very good</td><td>48.3</td><td>43</td><td>70.6</td><td></td></tr><tr><td> Good</td><td>39.3</td><td>35</td><td>21.5</td><td><.001</td></tr><tr><td> Fair/poor</td><td>12.4</td><td>11</td><td>7.9</td><td></td></tr><tr><td>How would you rate the health of your gums?</td><td></td><td></td><td>NA</td><td></td></tr><tr><td> Excellent</td><td>10.2</td><td>9</td><td></td><td></td></tr><tr><td> Very good</td><td>33.0</td><td>29</td><td></td><td></td></tr><tr><td> Good</td><td>43.2</td><td>38</td><td></td><td></td></tr><tr><td> Fair</td><td>12.5</td><td>11</td><td></td><td></td></tr><tr><td> Poor</td><td>1.1</td><td>1</td><td></td><td></td></tr><tr><td></td><td>%</td><td>95% CI</td><td>%</td><td><i>P</i>-value</td></tr><tr><td>What specific problems, if any, do you have with your teeth and gums?</td><td></td><td></td><td></td><td></td></tr><tr><td> Pain/toothache*</td><td>5.8</td><td>1.9–12.9</td><td>10</td><td>.19</td></tr><tr><td> Cavities/decayed teeth or cavities*</td><td>25.9</td><td>16.8–36.9</td><td>19.4</td><td>.14</td></tr><tr><td> Bleeding gums*</td><td>31.8</td><td>22.3–42.6</td><td>4.0</td><td><.001</td></tr><tr><td> Cosmetic concerns: discoloration**</td><td>40.7</td><td>30.2–51.8</td><td>3.6</td><td><.001</td></tr><tr><td> Orthodontic concerns: crooked teeth**</td><td>41.5</td><td>30.7–52.9</td><td>33.5</td><td>.13</td></tr><tr><td> Bad breath</td><td>26.7</td><td>17.8–37.4</td><td>NA</td><td></td></tr><tr><td> Plaque or tartar buildup on teeth**</td><td>33.3</td><td>22.9–45.2</td><td>3.6</td><td><.001</td></tr></table> |
a6336f952752e7a212acd6c9538c4cb4b3fd02ecb9cab73ba8eb17359236b859.png | complex | <table><tr><td></td><td></td><td colspan="2">Subset with airborne PAH monitoring and RCPM</td><td colspan="2">Subset with airborne PAH monitoring but missing RCPM</td></tr><tr><td>Variable</td><td><i>p</i>-Valueb</td><td>Mean ± SD</td><td><i>n</i>c</td><td>Mean ± SD</td><td><i>n</i>d</td></tr><tr><td colspan="6">Continuous</td></tr><tr><td> Total valid airborne PAH exposure (ng/m<sup>3</sup>)</td><td>0.65</td><td>39.62 ± 48.49</td><td>219</td><td>39.39 ± 47.70</td><td>125</td></tr><tr><td> Dietary exposure to PAHs during pregnancye</td><td>0.31</td><td>42.49 ± 5.65</td><td>219</td><td>43.14 ± 6.27</td><td>139</td></tr><tr><td> Cord blood cotinine level (ng/mL)</td><td>0.49</td><td>2.04 ± 11.52</td><td>219</td><td>3.29 ± 15.56</td><td>138</td></tr><tr><td> Cord blood lead level (μg/dL)</td><td>0.59</td><td>1.60 ± 1.19</td><td>210</td><td>1.51 ± 0.78</td><td>129</td></tr><tr><td> Cord blood mercury level (μg/dL)</td><td>0.43</td><td>1.07 ± 0.64</td><td>161</td><td>1.16 ± 0.79</td><td>106</td></tr><tr><td> Gestational age (days)</td><td>0.07</td><td>39.26 ± 1.73</td><td>219</td><td>39.51 ± 1.63</td><td>139</td></tr><tr><td> Birth weight (g)</td><td>0.01</td><td>3368.49 ± 508.38</td><td>219</td><td>3501.65 ± 474.22</td><td>139</td></tr><tr><td> Birth height (cm)</td><td>0.76</td><td>54.44 ± 3.06</td><td>219</td><td>54.54 ± 3.10</td><td>139</td></tr><tr><td> Head circumference at birth (cm)</td><td>0.21</td><td>33.81 ± 1.54</td><td>219</td><td>34.01 ± 1.47</td><td>139</td></tr><tr><td> Maternal age (years)</td><td>0.01</td><td>28.50 ± 3.59</td><td>219</td><td>27.49 ± 3.73</td><td>139</td></tr><tr><td> Maternal height (cm)</td><td>0.18</td><td>164.69 ± 5.71</td><td>219</td><td>165.52 ± 5.59</td><td>139</td></tr><tr><td> Maternal prepregnancy weight (kg)</td><td>0.95</td><td>58.44 ± 8.80</td><td>219</td><td>58.50 ± 9.32</td><td>139</td></tr><tr><td> Maternal TONI-3</td><td>0.23</td><td>33.48 ± 9.07</td><td>176</td><td>31.42 ± 9.71</td><td>31</td></tr><tr><td> Maternal blood cotinine level at birth (ng/mL)</td><td>0.97</td><td>1.68 ± 10.09</td><td>219</td><td>2.99 ± 14.34</td><td>138</td></tr><tr><td> Maternal blood lead level at birth (μg/dL)</td><td>0.79</td><td>1.92 ± 0.83</td><td>209</td><td>1.86 ± 0.66</td><td>136</td></tr><tr><td>Categorical</td><td><i>p</i>-Valuef</td><td>Proportion</td><td><i>n</i></td><td>Proportion</td><td><i>n</i></td></tr><tr><td> Caucasian race</td><td>1.00</td><td>1.00</td><td>219</td><td>1.00</td><td>139</td></tr><tr><td> Maternal education (proportion graduated high school, i.e., 12 years of schooling)</td><td>0.47</td><td>0.91</td><td>219</td><td>0.88</td><td>139</td></tr><tr><td> ETS in the home (yes = 1, no = 0)</td><td>0.52</td><td>0.22</td><td>219</td><td>0.25</td><td>139</td></tr><tr><td> Exposure to alcohol during pregnancy (yes = 1, no = 0)</td><td>0.18</td><td>0.60</td><td>219</td><td>0.67</td><td>139</td></tr><tr><td> Sex of the child (proportion female)</td><td>0.52</td><td>0.52</td><td>219</td><td>0.48</td><td>139</td></tr></table> |
228511d4b609b3cacd4c15b9a2f0dbf3e313f54d1c7e3775455bb2f1a3a2a52b.png | complex | <table><tr><td>Measures of socioeconomic position</td><td colspan="2">GP visits</td><td colspan="2">Specialist visits</td><td colspan="2">Hospitalisation</td></tr><tr><td></td><td colspan="2">PR<sup>a </sup>(IC 95%)</td><td colspan="2">PR<sup>a </sup>(IC 95%)</td><td colspan="2">PR<sup>a </sup>(IC 95%)</td></tr><tr><td>Education</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Tertiary</td><td>1.00</td><td>-</td><td>1.00</td><td>-</td><td>1.00</td><td>-</td></tr><tr><td>Upper secondary</td><td>1.21</td><td>(1.08–1.35)</td><td>0.90</td><td>(0.77–1.06)</td><td>0.95</td><td>(0.79–1.13)</td></tr><tr><td>Lower secondary</td><td>1.38</td><td>(1.23–1.54)</td><td>0.77</td><td>(0.64–0.91)</td><td>1.18</td><td>(0.98–1.41)</td></tr><tr><td>Primary/no education</td><td>1.52</td><td>(1.37–1.68)</td><td>0.66</td><td>(0.57–0.77)</td><td>1.16</td><td>(0.99–1.37)</td></tr><tr><td>Social class</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>I–II</td><td>1.00</td><td>-</td><td>1.00</td><td>-</td><td>1.00</td><td>-</td></tr><tr><td>III</td><td>1.14</td><td>(1.03–1.25)</td><td>0.85</td><td>(0.73–0.99)</td><td>0.96</td><td>(0.82–1.12)</td></tr><tr><td>IV</td><td>1.42</td><td>(1.30–1.55)</td><td>0.79</td><td>(0.69–0.91)</td><td>1.06</td><td>(0.92–1.22)</td></tr><tr><td>V–VI</td><td>1.43</td><td>(1.30–1.56)</td><td>0.67</td><td>(0.57–0.78)</td><td>1.12</td><td>(0.97–1.30)</td></tr><tr><td>Monthly income</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>More than 1800 euros</td><td>1.00</td><td>-</td><td>1.00</td><td>-</td><td>1.00</td><td>-</td></tr><tr><td>From 1201 to 1800 euros</td><td>1.24</td><td>(1.13–1.35)</td><td>0.81</td><td>(0.50–0.68)</td><td>1.05</td><td>(0.91–1.21)</td></tr><tr><td>From 901 to 1200 euros</td><td>1.21</td><td>(1.11–1.33)</td><td>0.72</td><td>(0.63–0.85)</td><td>1.01</td><td>(0.87–1.18)</td></tr><tr><td>Up to 900 euros</td><td>1.39</td><td>(1.27–1.51)</td><td>0.58</td><td>(0.71–0.93)</td><td>1.06</td><td>(0.92–1.22)</td></tr></table> |
f797252cec76887a0e9baf30a667babc8b27adc9c26a4d97b4d6c5df2800a26e.png | simple | <table><tr><td>Study (reference)</td><td>Country of study, n.</td><td>Primary exposure measure (birth weight, g)</td><td>Effect size (95% CI)</td><td>Age at follow up (y)</td><td>Quality score</td><td>Adjusted</td></tr><tr><td>Davidson [16]</td><td>England, n = 248612</td><td>1000-2999 vs 3000-3999</td><td>OR 1.2 (1.1-1.3)</td><td>2-10</td><td>8.0</td><td>Yes</td></tr><tr><td>Chatkin [15]</td><td>Brazil, n = 981</td><td>< 2500 vs >2500</td><td>RR 1.32 (0.8-1.96)</td><td>4-5</td><td>5.5</td><td>Yes</td></tr><tr><td>Nepomnyaschy [19]</td><td>United States, n = 1803</td><td>< 2500 vs >2500</td><td>RR 1.57 (1.23-1.99)</td><td>< 3</td><td>6.0</td><td>No</td></tr><tr><td>Fergusson [17]</td><td>New Zealand, n = 798</td><td>< 2500 vs 2500-4000</td><td>RR 0.97 (0.6-1.58)</td><td>16</td><td>5.5</td><td>No</td></tr><tr><td>Lu [18]</td><td>Taiwan, n = 69979</td><td>< 3000 vs 3000-4000</td><td>RR 1.17 (1.09-1.27)</td><td>13-15</td><td>7.0</td><td>No</td></tr><tr><td>Yuan [26]</td><td>Denmark, n = 10190</td><td>< 2500 vs 2500-4499</td><td>RR 0.9 (0.43-1.89)</td><td>< 12</td><td>6.5</td><td>No</td></tr><tr><td>Wjst [24]</td><td>German, n = 2337</td><td>< 2500 vs >2500</td><td>RR 1.47 (0.64-3.36)</td><td>5-14</td><td>5.0</td><td>No</td></tr><tr><td>Remes [21]</td><td>Finland, n = 4141</td><td>≤ 2490 vs 2500-4190</td><td>RR 1.31 (0.85-2)</td><td>16</td><td>7.0</td><td>No</td></tr><tr><td>Yang [25]</td><td>United States, n = 3933</td><td>< 2500 vs >2500</td><td>RR 1.25 (0.73-2.15)</td><td>6-7</td><td>6.5</td><td>No</td></tr><tr><td>Rasanen [20]</td><td>Finland, n = 4502</td><td>< 2500 vs >2500</td><td>RR 0.97 (0.71-1.31)</td><td>16</td><td>6.0</td><td>No</td></tr><tr><td>To [23]</td><td>Canada, n = 671402</td><td>< 2500 vs 2500-4500</td><td>RR 1.18 (1.13-1.22)</td><td>6</td><td>8.5</td><td>Yes</td></tr><tr><td>Sin [22]</td><td>Canada, n = 83595</td><td>< 2500 vs 2500-4500</td><td>RR 1 (0.9-1.11)</td><td>10</td><td>7.5</td><td>Yes</td></tr><tr><td>Bjerg [14]</td><td>Sweden, n = 3430</td><td>< 2500 vs >2500</td><td>OR 2.6 (1.2-5.4)</td><td>7-8</td><td>6.0</td><td>Yes</td></tr></table> |
2e005bbbb6c47d8f44673c3c4ae8fd169dfc428732dc45d971e9afdb51145fe5.png | simple | <table><tr><td>day0 Cow Nr</td><td>Heat score</td><td>day12 Cow Nr</td><td>Heat score</td></tr><tr><td>d0_5006</td><td>0</td><td>d12_1528</td><td>2</td></tr><tr><td>d0_9284</td><td>37</td><td>d12_9303</td><td>4</td></tr><tr><td>d0_3739</td><td>43</td><td>d12_8860</td><td>5</td></tr><tr><td>d0_8855</td><td>53</td><td>d12_1773</td><td>75</td></tr><tr><td>d0_1194</td><td>137</td><td>d12_8873</td><td>157</td></tr><tr><td>d0_1821</td><td>175</td><td>d12_7724</td><td>198</td></tr><tr><td>d0_8870</td><td>191</td><td>d12_1520</td><td>257</td></tr><tr><td>d0_5507</td><td>200</td><td>d12_7942</td><td>275</td></tr><tr><td>d0_1786</td><td>206</td><td>d12_1607</td><td>318</td></tr><tr><td>d0_3472</td><td>246</td><td>d12_1822</td><td>368</td></tr><tr><td>d0_6487</td><td>248</td><td>d12_1638</td><td>383</td></tr><tr><td>d0_3747</td><td>378</td><td>d12_6956</td><td>404</td></tr><tr><td>d0_7008</td><td>405</td><td>d12_8857</td><td>475</td></tr><tr><td>d0_5125 *</td><td>1750</td><td>d12_2540</td><td>505</td></tr></table> |
e65f2b5d49287740d23edb39da58d7cd7a5d34fdd8fd7cf0fe26f7fb3b637d8c.png | complex | <table><tr><td>Descriptor</td><td>FTU Dosing Study</td><td>Tape-Stripping Study</td></tr><tr><td>Age (years)</td><td>27.2 ± 10.3</td><td>26.0 ± 3.7</td></tr><tr><td>Gender</td><td>14 male; 10 female</td><td>3 female; 2 male</td></tr><tr><td>Fingertip length (mm)</td><td>28 ± 3</td><td>Not applicable</td></tr><tr><td>Previous use of TCS</td><td>9 yes; 15 no</td><td>No recent use</td></tr><tr><td>PIL offered?</td><td>12 yes; 12 no</td><td rowspan="2">Not applicable</td></tr><tr><td>If yes; PIL read?</td><td>8 yes; 4 no</td></tr></table> |
42d17ec4fa5385380919e74cd109ffb193a6fe84796d4a50068ce07028edcaa8.png | complex | <table><tr><td rowspan="2">Biological factor observed</td><td colspan="3">MONET study</td><td colspan="3">CAO study</td><td rowspan="2"><i>P</i>-value</td></tr><tr><td>Mean</td><td>Std. Dev.</td><td>Size (<i>n</i>)</td><td>Mean</td><td>Std. Dev</td><td>Size (<i>n</i>)</td></tr><tr><td>Age (yrs)</td><td>58.1</td><td>4.91</td><td>62</td><td>56.7</td><td>4.18</td><td>27</td><td>0.230</td></tr><tr><td>Height (m)</td><td>1.61</td><td>0.06</td><td>62</td><td>1.63</td><td>0.08</td><td>27</td><td>0.189</td></tr><tr><td colspan="8">Pre-Intervention</td></tr><tr><td> BMI (kg/m<sup>2</sup>)</td><td>35.3</td><td>4.04</td><td>62</td><td>34.7</td><td>3.37</td><td>27</td><td>0.489</td></tr><tr><td> Lean Mass (kg)</td><td>45.5</td><td>6.82</td><td>62</td><td>46.1</td><td>7.38</td><td>27</td><td>0.693</td></tr><tr><td> Fat Mass (kg)</td><td>43.9</td><td>8.64</td><td>62</td><td>44.2</td><td>9.10</td><td>27</td><td>0.898</td></tr><tr><td> Lean Mass (%)</td><td>49.6</td><td>4.43</td><td>62</td><td>49.7</td><td>3.71</td><td>27</td><td>0.888</td></tr><tr><td> Fat Mass (%)</td><td>47.6</td><td>4.48</td><td>62</td><td>47.3</td><td>3.82</td><td>27</td><td>0.753</td></tr><tr><td> Visceral Fat (cm<sup>2</sup>)</td><td>207</td><td>51.9</td><td>61</td><td>206</td><td>52.8</td><td>27</td><td>0.927</td></tr><tr><td> Muscle Attenuation (HU)</td><td>48.5</td><td>3.70</td><td>62</td><td>48.6</td><td>2.20</td><td>27</td><td>0.833</td></tr><tr><td colspan="8">Post-Intervention</td></tr><tr><td> BMI (kg/m<sup>2</sup>)</td><td>33.0</td><td>4.42</td><td>61</td><td>32.8</td><td>3.24</td><td>27</td><td>0.813</td></tr><tr><td> Lean Mass (kg)</td><td>44.1</td><td>5.69</td><td>60</td><td>44.1</td><td>6.58</td><td>27</td><td>0.998</td></tr><tr><td> Fat Mass (kg)</td><td>39.1</td><td>9.90</td><td>60</td><td>41.1</td><td>8.78</td><td>27</td><td>0.361</td></tr><tr><td> Lean Mass (%)</td><td>51.9</td><td>5.28</td><td>60</td><td>50.4</td><td>3.99</td><td>27</td><td>0.184</td></tr><tr><td> Fat Mass (%)</td><td>45.1</td><td>5.41</td><td>60</td><td>46.5</td><td>4.19</td><td>27</td><td>0.254</td></tr><tr><td> Visceral Fat (cm<sup>2</sup>)</td><td>182</td><td>58.5</td><td>60</td><td>182</td><td>47.4</td><td>27</td><td>0.981</td></tr><tr><td> Muscle Attenuation (HU)</td><td>48.2</td><td>4.09</td><td>61</td><td>48.6</td><td>1.89</td><td>27</td><td>0.661</td></tr></table> |
011059f45fc86ed3d092908be12c273a3acfc50b6edfd7fc289500322962824b.png | simple | <table><tr><td>Author</td><td>Year</td><td>Country</td><td>Limb</td><td>Test timing, h</td></tr><tr><td>Arlettaz et al.</td><td>2006</td><td>Switzerland</td><td>Right or left foot</td><td>6–12</td></tr><tr><td>Bakr and Habib</td><td>2005</td><td>Egypt</td><td>Right upper and lower limbs</td><td>31.7 (average)</td></tr><tr><td>de Wahl Granelli et al.</td><td>2005</td><td>Sweden</td><td>Right hand and one foot</td><td>12–48</td></tr><tr><td>Hoke et al.</td><td>2002</td><td>America</td><td>Right arm and either leg</td><td>24 (average)</td></tr><tr><td>Koppel et al.</td><td>2003</td><td>America</td><td>—</td><td>>24</td></tr><tr><td>Richmond et al.</td><td>2002</td><td>UK</td><td>One or other foot</td><td>>2</td></tr><tr><td>Rosati et al.</td><td>2005</td><td>Italy</td><td>—</td><td>72 h (median)</td></tr><tr><td>Zhao et al.</td><td>2014</td><td>China</td><td>Both on the right hand and on either foot</td><td>6–72</td></tr><tr><td>Riede et al.</td><td>2010</td><td>Germany</td><td>Foot</td><td>24–72</td></tr><tr><td>Mathur et al.</td><td>2015</td><td>India</td><td>Right upper limb and either foot</td><td>72 (median)</td></tr><tr><td>Hu et al.</td><td>2016</td><td>China</td><td>Right hand and either foot</td><td>25 (median)</td></tr><tr><td>Jones et al.</td><td>2016</td><td>UK</td><td>—</td><td><24</td></tr><tr><td>Ozalkaya et al.</td><td>2016</td><td>Turkey</td><td>Lower and right upper extremity</td><td>>24</td></tr><tr><td>Jawin et al.</td><td>2015</td><td>Malaysia</td><td>Left foot</td><td>20 (median)</td></tr><tr><td>Ewer et al.</td><td>2011</td><td>UK</td><td>Right hand and either foot</td><td>In the first few hours</td></tr><tr><td>Taksande et al.</td><td>2013</td><td>India</td><td>All the four limbs</td><td>Within the first 4 hours</td></tr><tr><td>van Niekerk et al.</td><td>2016</td><td>South Africa</td><td>—</td><td>60 (median)</td></tr><tr><td>de-Wahl Granelli et al.</td><td>2009</td><td>Sweden</td><td>Right hand and either foot</td><td>38 (median)</td></tr><tr><td>Meberg et al.</td><td>2008</td><td>Norway</td><td>Foot</td><td><12</td></tr><tr><td>Mo et al.</td><td>2015</td><td>China</td><td>Right hand and either foot</td><td>>24</td></tr><tr><td>Jia et al.</td><td>2016</td><td>China</td><td>Right hand</td><td>24</td></tr><tr><td>Lu et al.</td><td>2016</td><td>China</td><td>Right hand and right foot</td><td>>24</td></tr></table> |
b14dd2a353b71f5fcb45d33853cbe4f90f70b7678ce752a6db63aef5124ccc67.png | complex | <table><tr><td></td><td colspan="2">Model 1</td><td colspan="2">Model2</td><td colspan="2">Model 3</td><td colspan="2">Model 4<sup>a</sup></td></tr><tr><td></td><td>OR</td><td>95 % CI</td><td>OR</td><td>95 % CI</td><td>OR</td><td>95 % CI</td><td>OR</td><td>95 % CI</td></tr><tr><td>Open unemployment 18–21 (no exp. ref.)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td>2.53***</td><td>1.82–3.52</td><td></td><td></td><td>2.53***</td><td>1.77–3.60</td><td>2.48***</td><td>1.57–3.60</td></tr><tr><td>Youth programs 18–21 (no exp. ref.)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td></td><td></td><td>1.24</td><td>0.97–1.59</td><td>1.01</td><td>0.78–1.31</td><td>0.95</td><td>0.72–1.26</td></tr><tr><td>IMHS at age 16</td><td>1.58***</td><td>1.45–1.72</td><td>1.58***</td><td>1.45–1.72</td><td>1.58***</td><td>1.45–1.72</td><td>1.46***</td><td>1.34–1.60</td></tr><tr><td>Pseudo R-square</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cox and Snell</td><td>0.12</td><td></td><td>0.10</td><td></td><td>0.12</td><td></td><td>0.15</td><td></td></tr><tr><td>Nagelkerke</td><td>0.13</td><td></td><td>0.11</td><td></td><td>0.13</td><td></td><td>0.16</td><td></td></tr></table> |
0c82bc241238f43acd12430f75bd6c28d8dca9d598c3edb873f14ccf0dcd45af.png | simple | <table><tr><td>ID</td><td>HISTOLOGY</td><td>Age at diagnosis(years)</td><td>Race</td><td>Smoking</td><td>Drinking</td><td>Menopausal status</td><td>BMI (Kg/m<sup>2</sup>)</td><td>CYP1B1(V432L) *</td></tr><tr><td>5</td><td>Intra Ductal Carcinoma</td><td>68</td><td>White</td><td>Never</td><td>Unknown</td><td>Post</td><td>51.16</td><td>Wild type</td></tr><tr><td>8</td><td>Intra Ductal Carcinoma</td><td>45</td><td>White</td><td>Never</td><td>No</td><td>Pre</td><td>38.39</td><td>Wild type</td></tr><tr><td>9</td><td>Intra Ductal and Lobular Carcinoma</td><td>51</td><td>White</td><td>Never</td><td>No</td><td>Post</td><td>26.63</td><td>Wild type</td></tr><tr><td>1</td><td>Intra Ductal Carcinoma</td><td>44</td><td>White</td><td>Never</td><td>Yes</td><td>Pre</td><td>22.49</td><td>Heterozygous</td></tr><tr><td>2</td><td>Intra Ductal Carcinoma</td><td>56</td><td>White</td><td>Never</td><td>No</td><td>Post</td><td>37.12</td><td>Heterozygous</td></tr><tr><td>6</td><td>Intra Ductal Carcinoma</td><td>69</td><td>White</td><td>Never</td><td>No</td><td>Post</td><td>35.51</td><td>Heterozygous</td></tr><tr><td>3</td><td>Intra Ductal Carcinoma</td><td>60</td><td>White</td><td>Never</td><td>No</td><td>Post</td><td>21.45</td><td>Homozygous variant</td></tr><tr><td>4</td><td>Intra Ductal Carcinoma</td><td>67</td><td>White</td><td>Never</td><td>Yes</td><td>Post</td><td>27.36</td><td>Homozygous variant</td></tr><tr><td>7</td><td>Metaplastic carcinoma</td><td>46</td><td>White</td><td>Never</td><td>No</td><td>post</td><td>23.51</td><td>Homozygous variant</td></tr></table> |
818e1f55c14e318c9b26f81eca3212f98ac0b537e4a78dc29167c08ce43719b9.png | complex | <table><tr><td colspan="2">Type of use</td><td>Unit costs</td></tr><tr><td rowspan="10">Costs in the health care system (public/private)</td><td>General practitioner</td><td>10.5/27.5</td></tr><tr><td>Nurse or psychiatric nurse</td><td>10.0/25.4</td></tr><tr><td>Social worker</td><td>14.9/25.4</td></tr><tr><td>Psychologist</td><td>70.6/70.6</td></tr><tr><td>Psychiatrist</td><td>42.9/42.9</td></tr><tr><td>Other medical specialists</td><td>51.1/51.1</td></tr><tr><td>Hospital emergency visits</td><td>155.5</td></tr><tr><td>Hospital stay</td><td>617.5</td></tr><tr><td>Diagnostic tests (range)</td><td>4.3 to 434.6</td></tr><tr><td>Pharmacologic treatment</td><td>Depending on type and dose</td></tr><tr><td>Productivity losses</td><td>Absenteeism from work (minimum and medium daily wage)</td><td>21.4 to 62.7</td></tr><tr><td>CBT costs</td><td>Cost of the group intervention per session (eight patients/group; nine sessions)</td><td>240</td></tr></table> |
51448db4e967d07f07428f552c585918a06adaa7bf94a5c164d6a52f2e1554aa.png | complex | <table><tr><td rowspan="2">Year</td><td colspan="4">Prevalence rate (per 1000 population)</td></tr><tr><td colspan="2">Males (95% CI)</td><td colspan="2">Females (95% CI)</td></tr><tr><td> </td><td>70-74 years</td><td>≥ 75 years</td><td>70-74 years</td><td>≥ 75 years</td></tr><tr><td>2002</td><td>11.1 (10.5-11.6)</td><td>8.0 (7.6-8.4)</td><td>21.0 (20.4-21.7)</td><td>13.1 (12.6-13.6)</td></tr><tr><td>2003</td><td>18.9 (18.3-19.5)</td><td>14.2 (13.7-14.7)</td><td>35.8 (35.0-36.6)</td><td>23.3 (22.7-24.0)</td></tr><tr><td>2004</td><td>25.1 (24.3-25.9)</td><td>20.5 (19.9-21.2)</td><td>50.0 (49.0-50.9)</td><td>31.9 (31.1-32.6)</td></tr><tr><td>2005</td><td>32.8 (32.0-33.5</td><td>25.4 (24.7-26.1)</td><td>64.1 (63.1-65.2)</td><td>39.5 (38.6-40.3)</td></tr><tr><td>2006</td><td>38.1 (37.2-38.9)</td><td>32.3 (31.5-33.1)</td><td>73.6 (72.4-74.7)</td><td>48.6 (47.6-49.5)</td></tr><tr><td>2007</td><td>43.9 (43.0-44.8)</td><td>37.8 (36.9-38.6)</td><td>83.1 (81.9-84.3)</td><td>56.2 (55.2-57.2)</td></tr><tr><td>2008</td><td>49.1 (48.2-50.1)</td><td>41.0 (40.1-41.9)</td><td>94.8 (93.5-96.1)</td><td>62.2 (61.1-63.2)</td></tr><tr><td>2009</td><td>58.7 (56.8-60.7)</td><td>46.3 (45.0-47.7)</td><td>110.8 (108.3-113.3)</td><td>68.6 (67.2-69.9)</td></tr><tr><td>2010</td><td>58.0 (56.1-60.0)</td><td>44.3 (42.9-45.6)</td><td>109.7 (107.2-112.2)</td><td>68.1 (66.8-69.5)</td></tr><tr><td>2011</td><td>47.3 (45.7-49.0)</td><td>43.3 (42.0-44.7)</td><td>93.8 (91.6-96.0)</td><td>67.2 (65.8-68.5)</td></tr></table> |
e4c7ac822d36a8db896ebbbb2917f19f74dad20dd7fd5dcca65deb3926ebffec.png | simple | <table><tr><td> </td><td>Case 1</td><td>Case 2</td><td>Case 3</td><td>Case 4</td><td>Case totals</td><td>Stakeholders</td><td>Total</td></tr><tr><td>Sharp-end interviews</td><td>17</td><td>4</td><td>0</td><td>12</td><td>33</td><td>98</td><td> </td></tr><tr><td>Blunt-end interviews</td><td>7</td><td>0</td><td>20</td><td>10</td><td>37</td><td></td><td></td></tr><tr><td>Total</td><td>24</td><td>4</td><td>20</td><td>22</td><td>70</td><td>98</td><td>168</td></tr></table> |
ef4c7af62ccd6d6834e04a4ac6395f19340e146e6c97a834dc00de0bb0e8aec7.png | complex | <table><tr><td></td><td></td><td></td><td></td><td></td><td colspan="4">Novel</td></tr><tr><td>Filter</td><td>Protein coding</td><td>Antisense</td><td>Pseudogene</td><td>Annotated lncRNA</td><td>Intronic</td><td>Intergenic</td><td>Interleaving</td><td>Encompassing</td></tr><tr><td>Raw</td><td>16,246</td><td>2,902</td><td>3,670</td><td>4,593</td><td>823</td><td>1,825</td><td>142</td><td>113</td></tr><tr><td>≥5% (11) samples</td><td>16,225</td><td>2,897</td><td>3,650</td><td>4,585</td><td>822</td><td>1,820</td><td>141</td><td>112</td></tr><tr><td>Distance (≥2 kb)</td><td>16,225</td><td>2,897</td><td>3,650</td><td>4,585</td><td>336</td><td>1,269</td><td>22</td><td>46</td></tr><tr><td>Mappability</td><td>14,468</td><td>2,338</td><td>1,698</td><td>3,646</td><td>249</td><td>993</td><td>18</td><td>36</td></tr><tr><td>Length (≥200 bp)</td><td>14,461</td><td>2,336</td><td>1,693</td><td>3,642</td><td>244</td><td>984</td><td>18</td><td>36</td></tr><tr><td>≥216 mapped reads</td><td>14,011</td><td>2,294</td><td>1,476</td><td>2,942</td><td>196</td><td>840</td><td>15</td><td>29</td></tr></table> |
80d3af0e118f1e7036b37bf19a5d5c2b001b0a39c0956f845d0a63f06add5afc.png | simple | <table><tr><td>Number of antimicrobial classes to which isolates exhibited resistance</td><td>Number of isolates</td><td>Percent</td><td>95% CI<sup>a</sup></td></tr><tr><td>1</td><td>17</td><td>26.6</td><td>16.3, 39.1</td></tr><tr><td>2</td><td>12</td><td>18.8</td><td>10.1, 30.4</td></tr><tr><td>3</td><td>7</td><td>10.9</td><td>4.5, 21.2</td></tr><tr><td>4</td><td>12</td><td>18.8</td><td>10.1, 30.4</td></tr><tr><td>5</td><td>8</td><td>12.5</td><td>5.6, 23.2</td></tr><tr><td>6</td><td>8</td><td>12.5</td><td>5.6, 23.2</td></tr></table> |
aa7d138c2f210737ff23d018cf160c8cb6079094f1597b9f6349baaeca84919c.png | simple | <table><tr><td>Health care utilization n (%)</td><td>Total study sample (n = 229493)</td><td>Non-multi-morbid (n = 53741)</td><td>Multi-morbid (n = 175752)</td><td><i>Sign.</i></td></tr><tr><td>Individuals with consultation</td><td>209'962 (91.5)</td><td>36'922 (68.7)</td><td>173'040 (98.5)</td><td>***</td></tr><tr><td>By primary care physicians</td><td>185'035 (80.6)</td><td>27'397 (51.0)</td><td>157'638 (89.7)</td><td>***</td></tr><tr><td>By specialists</td><td>165'178 (72.0)</td><td>25'834 (48.1)</td><td>139'344 (79.3)</td><td>***</td></tr><tr><td>Hospital outpatient visits</td><td>108'502 (47.3)</td><td>12'168 (22.6)</td><td>96'334 (54.8)</td><td>***</td></tr><tr><td>By different primary care physicians</td><td>41'601 (18.1)</td><td>3'494 (6.5)</td><td>38'107 (21.7)</td><td>***</td></tr><tr><td>By different specialists</td><td>108'187 (47.1)</td><td>13'029 (24.2)</td><td>95'158 (54.1)</td><td>***</td></tr><tr><td>Individuals with physician contact</td><td></td><td></td><td></td><td></td></tr><tr><td>Face-to-face consultations</td><td>203'328 (88.6)</td><td>34'129 (63.5)</td><td>169'199 (96.3)</td><td>***</td></tr><tr><td>Phone consultations</td><td>55'174 (24.0)</td><td>4'748 (8.8)</td><td>50'426 (28.7)</td><td>***</td></tr><tr><td>Home visits</td><td>14'059 (6.1)</td><td>654 (1.2)</td><td>13'405 (7.6)</td><td>***</td></tr><tr><td>Individuals with hospitalisation</td><td>40'556 (17.7)</td><td>2'091 (3.9)</td><td>38'465 (21.9)</td><td>***</td></tr></table> |
e89af561fbdc8b1736a988e6c7dbedc9672e77134288be29190aa1eb191321ab.png | complex | <table><tr><td> </td><td colspan="6">FH Phenotype</td><td colspan="4">Gender</td></tr><tr><td> </td><td colspan="2">Y<sup>402</sup></td><td colspan="2">Y<sup>402</sup>H</td><td colspan="2">H<sup>402</sup></td><td colspan="2">AMD</td><td colspan="2">Control</td></tr><tr><td>Protein (mg/ml)</td><td>AMD</td><td>Control</td><td>AMD</td><td>Control</td><td>AMD</td><td>Control</td><td>Male</td><td>Female</td><td>Male</td><td>Female</td></tr><tr><td>CFH</td><td>0.7±0.2</td><td>0.6±0.1</td><td>0.7±0.1</td><td>0.6±0.2</td><td>0.7±0.2</td><td>0.6±0.1</td><td>0.6±0.2</td><td>0.7±0.2</td><td>0.6±0.2</td><td>0.6±0.2</td></tr><tr><td>C3</td><td>1.6±0.6</td><td>1.5±1</td><td>1.5±0.7</td><td>1.7±1.1</td><td>1.6±0.8</td><td>1.5±0.8</td><td>1.3±0.7</td><td>1.7±0.7</td><td>1.5±0.9</td><td>1.6±1.1</td></tr><tr><td>CRP</td><td>0.9±3.7</td><td>0.4±0.4</td><td>0.5±0.5</td><td>0.4±0.5</td><td>0.7±1.5</td><td>0.6±1.1</td><td>1± 3.2</td><td>0.5±0.5</td><td>0.4±0.5</td><td>0.5±0.6</td></tr></table> |
170166051dcb753466695338f4c66a3e25263bd7f94dbb4659321cbef24b8743.png | complex | <table><tr><td> </td><td colspan="3">Total population</td><td>AF</td><td colspan="2"> </td><td colspan="2">Non-AF</td><td> </td><td>P-value</td></tr><tr><td> </td><td colspan="3"> </td><td> </td><td><i>detection rate (%)</i></td><td><i>95% CI</i></td><td colspan="4"> </td></tr><tr><td>Total, n</td><td colspan="3">928</td><td>35</td><td>3.8%</td><td>(2.7–5.2)</td><td colspan="4">893</td></tr><tr><td>Men, n (%)</td><td colspan="3">462 (49.8%)</td><td>21 (60.0%)</td><td>4.6%</td><td>(3.0–6.8)</td><td colspan="2">441 (49.4%)</td><td> </td><td>0.218</td></tr><tr><td>Women, n (%)</td><td colspan="3">466 (50.2%)</td><td>14 (40.0%)</td><td>3.0%</td><td>(1.8–5.0)</td><td colspan="2">452 (50.6%)</td><td> </td><td> </td></tr><tr><td>Age < 65 years, n (%)</td><td colspan="3">242 (26.1%)</td><td>7 (20.0%)</td><td>2.9%</td><td>(1. 4–5.8)</td><td colspan="2">235 (26.3%)</td><td> </td><td>0.404</td></tr><tr><td>Age ≥65 years, n (%)</td><td colspan="3">686 (73.9%)</td><td>28 (80.0%)</td><td>4.1%</td><td>(2.8–5.8)</td><td colspan="2">658 (73.7%)</td><td> </td><td> </td></tr><tr><td>CHADS2 = 1, n (%)</td><td colspan="3">415 (44.7%)</td><td>13 (37.1%)</td><td>3.1%</td><td>(1.7–5.1)</td><td colspan="2">403 (45.1%)</td><td> </td><td>0.351</td></tr><tr><td>CHADS2 ≥ 2, n (%)</td><td colspan="3">513 (55.3%)</td><td>22 (62.9%)</td><td>4.3%</td><td>(2.8–6.3)</td><td colspan="2">490 (54.9%)</td><td> </td><td> </td></tr><tr><td>CHF, n (%)</td><td colspan="3">34 (3.7%)</td><td>1 (2.9%)</td><td>2.9%</td><td>(0.7–14.9)</td><td colspan="2">33 (3.7%)</td><td> </td><td>0.796</td></tr><tr><td>HT, n (%)</td><td colspan="3">838 (90.3%)</td><td>31 (88.6%)</td><td>3.7%</td><td>(2.6–5.2)</td><td colspan="2">807 (90.4%)</td><td> </td><td>0.724</td></tr><tr><td>Age ≥75 y, n (%)</td><td colspan="3">326 (35.0%)</td><td>13 (37.1%)</td><td>4.0%</td><td>(2.6–7.1)</td><td colspan="2">313 (35.1%)</td><td> </td><td>0.799</td></tr><tr><td>DM, n (%)</td><td colspan="3">293 (31.6%)</td><td>12 (34.3%)</td><td>4.1%</td><td>(2.4–7.0)</td><td colspan="2">281 (31.5%)</td><td> </td><td>0.725</td></tr><tr><td>ES, n (%)</td><td colspan="3">80 (8.6%)</td><td>4 (11.4%)</td><td>5.0%</td><td>(2.0–12.2)</td><td colspan="2">76 (8.5%)</td><td> </td><td>0.546</td></tr><tr><td>IHD*, n (%)</td><td colspan="3">184 (19.8%)</td><td>5 (14.3%)</td><td>2.7%</td><td>(1.2–6.2)</td><td colspan="2">179 (20.0%)</td><td> </td><td>0.402</td></tr><tr><td> </td><td colspan="3">Total population</td><td>AF</td><td> </td><td> </td><td colspan="3">Non-AF</td><td> </td></tr><tr><td> </td><td><i>Mean</i></td><td><i>SD</i></td><td><i>Range</i></td><td><i>Mean</i></td><td><i>SD</i></td><td><i>Range</i></td><td><i>Mean</i></td><td><i>SD</i></td><td><i>Range</i></td><td><i>P-value</i></td></tr><tr><td>Number of ECG registrations, n</td><td>55.4</td><td>± 11.2</td><td>1–125</td><td>50.3</td><td>± 22.1</td><td>1–96</td><td>55.6</td><td>± 10.5</td><td>20–125</td><td>0.442</td></tr><tr><td>Age, y</td><td>69.8</td><td>± 9.4</td><td>33–89</td><td>70.7</td><td>± 7.7</td><td>53–85</td><td>69.8</td><td>± 9.4</td><td>33–89</td><td>0.679</td></tr><tr><td> </td><td><i>Median</i></td><td> </td><td><i>Range</i></td><td><i>Median</i></td><td> </td><td><i>Range</i></td><td><i>Median</i></td><td> </td><td><i>Range</i></td><td> </td></tr><tr><td>CHADS<sub>2 </sub>total</td><td>2</td><td> </td><td>1–5</td><td>2</td><td> </td><td>1–4</td><td>2</td><td> </td><td>1–5</td><td>0.451</td></tr></table> |
19d47c53f245b188694e92861e9ba9eeb58bb12ed79d1fb1cdcb990d230e4570.png | complex | <table><tr><td> </td><td colspan="2">Number (%) of patients</td><td> </td></tr><tr><td>Complications</td><td>Young group</td><td>Older group</td><td><i>P </i>value</td></tr><tr><td>Overall</td><td>16 (23.0%)</td><td>19 (22.9%)</td><td>0.928</td></tr><tr><td> Ascites</td><td>2 (2.8%)</td><td>1 (1.2%)</td><td>0.326</td></tr><tr><td> Wound infection</td><td>2(2.8%)</td><td>2(2.4%)</td><td>0.657</td></tr><tr><td> Pleural effusion</td><td>1(1.4%)</td><td>1(1.2%)</td><td>0.536</td></tr><tr><td> Pulmonary infection</td><td>1(1.4%)</td><td>11(13.3%)</td><td>0.041</td></tr><tr><td> Biliary fistula</td><td>2 (2.8%)</td><td>1(1.2%)</td><td>0.326</td></tr><tr><td> Liver failure</td><td>2(2.8%)</td><td>1(1.2%)*</td><td>0.326</td></tr><tr><td> Bleeding</td><td>6(8.6%)</td><td>2(2.4%)</td><td>0.084</td></tr></table> |
9417d830da3bcc343c90c31a9ff2b636340a38037a07dea952a08e7c755e3ff4.png | simple | <table><tr><td>Variable</td><td>Hazard ratio</td><td>95% CIs</td><td><i>P</i></td></tr><tr><td>GCB/Non-GCB</td><td>0.316</td><td>0.158–0.633</td><td>0.001</td></tr><tr><td>IPI score</td><td>4.218</td><td>2.235–7.962</td><td>0.000</td></tr><tr><td>GG + GC/CC</td><td>0.343</td><td>0.173–0.679</td><td>0.002</td></tr></table> |
70c7ebc770e13242d4fdda8ce0005478826997347cfa942c0150d3bac19fe023.png | complex | <table><tr><td>Variable</td><td></td><td></td><td></td><td></td></tr><tr><td><i>Age</i></td><td>56–65 years: 58(43%)</td><td>46–55 years: 37(27.4%)</td><td>36–45 years: 24(17.8%)</td><td>Under 35 years: 11(8.1%)</td></tr><tr><td rowspan="2"><i>Contract with sickness fund</i></td><td rowspan="2">§ 2-Vertrag (regional sickness funds): 86(78.5%)</td><td rowspan="2">Small sickness funds (BVA, SVA, KFA, VA, SVB): 90(78. 9%)</td><td rowspan="2">“Wahlarztstatus” (private doctor<sup>a</sup>): 22(16%)</td><td>“Wohnsitzärzte”<sup>b</sup>: 11(8.1%)</td></tr><tr><td>Locum physician: 16(12%)</td></tr><tr><td><i>Assistance</i></td><td>Receptionist: 120(90.2%)</td><td>Practice nurse: 34(25.6%)</td><td>Secretary: 48(36.1%)</td><td><i>Other employees:</i>Cleaning worker: 29Masseur: 7Physiotherapist: 4Medical technical assistant: 3</td></tr><tr><td><i>Number of inhabitants in the area of the office</i></td><td><4999: 68(50.7%)</td><td>5000–99,999: 22(16.4%)</td><td>10,000–29,999: 12(9%)</td><td>>30,000: 32(23.9%)</td></tr><tr><td><i>“Regelfälle”</i><sup><i>c</i></sup><i>/quarter</i></td><td><500 “Regelfälle”: 13(10.2%)</td><td>500–1000 “Regelfälle”: 24(18.8%)</td><td>1001–1500 “Regelfälle”: 61(47.7%)</td><td>>1500 “Regelfälle”: 30(23.4%)</td></tr><tr><td><i>Specialized office</i></td><td>Yes: 69 (51.95%)</td><td>No: 64 (48.1%)</td><td>–</td><td>–</td></tr><tr><td rowspan="2"><i>Field of practice specialization</i></td><td><i>17 GPs:</i>Complementary medicine</td><td rowspan="2"><i>8 GPs in each:</i>Manual medicineOrthopedicsSports medicine</td><td rowspan="2"><i>7 GPs in each:</i>NutritionGeriatricsPsychosocial/psychosomatic medicine</td><td rowspan="2"><i><6 GPs in each:</i>Preventive medicineHypertensionPain medicineOccupational medicineEmergency medicinePsychotherapyWound management</td></tr><tr><td><i>15 GPs:</i> Diabetes mellitus II management</td></tr></table> |
d842a001a32b283347813e177f3c6a1c054eed52cbd59cd3b9312e6e6f7e3dcc.png | simple | <table><tr><td></td><td></td><td>Never smoker</td><td></td><td>Smoker</td></tr><tr><td></td><td>COPD (%)</td><td>Adjusted OR(95%CI)</td><td>COPD (%)</td><td>Adjusted OR(95%CI)</td></tr><tr><td>Educational level</td><td></td><td></td><td></td><td></td></tr><tr><td> ≥ 12 years</td><td>101 (1.3)</td><td>1</td><td>80 (2.2)</td><td>1</td></tr><tr><td> 9-11 years</td><td>142 (1.4)</td><td>1.06 (0.81-1.37)</td><td>191 (3.1)</td><td>1.36 (1.04-1.78)</td></tr><tr><td> < 9 years</td><td>509 (3.5)</td><td>1.77 (1.40-2.25)</td><td>392 (5.8)</td><td>1.64 (1.26-2.12)</td></tr><tr><td> P for trend</td><td></td><td>< 0.001</td><td></td><td>< 0.001</td></tr><tr><td>Household Income</td><td></td><td></td><td></td><td></td></tr><tr><td> High</td><td>162 (1.8)</td><td>1</td><td>132 (3.2)</td><td>1</td></tr><tr><td> Middle</td><td>213 (2.0)</td><td>1.08 (0.87-1.34)</td><td>186 (3.3)</td><td>0.88 (0.69-1.11)</td></tr><tr><td> Low</td><td>305 (3.3)</td><td>1.31 (1.05-1.62)</td><td>284 (5.6)</td><td>1.17 (0.93-1.48)</td></tr><tr><td> P for trend</td><td></td><td>0.011</td><td></td><td>0.071</td></tr></table> |
f507db678ffdd395f90550c4a455b682b652d30db0edbd6d67cd2ff3360b5b43.png | simple | <table><tr><td>Differentiation</td><td>Subset</td><td>Surface phenotype</td></tr><tr><td>Progenitor subsets (bone marrow)</td><td>Pro-B</td><td>B220loCD43+</td></tr><tr><td> </td><td> </td><td>AA4.1+</td></tr><tr><td> </td><td>Pre-B</td><td>B220loCD43−, AA4.1+preBcR+</td></tr><tr><td> </td><td>Immature (23−)</td><td>B220lo, sIgM+, sIgD−, CD23−</td></tr><tr><td> </td><td>Immature (23+)</td><td>CD19+, B220+, sIgM+, sIgD−, CD23+</td></tr><tr><td>Transitional subsets (spleen)</td><td>T1</td><td>IgMhiCD23−, B220intAA4.1+</td></tr><tr><td> </td><td>T2</td><td>IgMhiCD23+, B220+AA4.1+</td></tr><tr><td> </td><td>T3</td><td>IgMloCD23+, B220+AA4.1+</td></tr><tr><td>Mature primary subsets</td><td>Follicular zone</td><td>IgMloCD23+, B220hiAA4.1−</td></tr><tr><td> </td><td>Marginal zone </td><td>CD19+IgMhiIgDlo CD23+ CD21+</td></tr><tr><td> </td><td>B1</td><td>CD43+ CD23− CD5+</td></tr><tr><td>T-independent responses</td><td>Early antibody-forming cells/short-lived plasma cells</td><td>B220loCD19+slg+iclghi</td></tr><tr><td>T-dependent responses</td><td>Early antibody-forming cells/short-lived plasma cells</td><td>B220loCD19+slg+iclghi</td></tr><tr><td> </td><td>Germinal center</td><td>B220+CD19+GL7+</td></tr><tr><td> </td><td>Long-lived plasma cells</td><td>B220loslg−iclg+</td></tr><tr><td> </td><td>Memory</td><td>B220+slg+IgD−</td></tr><tr><td>Natural antibodies</td><td>Peritoneal B1a and B1b</td><td>CD43+ CD23− CD5+</td></tr></table> |
f87f158b262d6bcef780277cf46cab4da13a4c39e5bdd7b1a439e21c3c025171.png | complex | <table><tr><td></td><td colspan="5">Pre-challenge Type 2 Neutralizing Antibody Level (log<sub>2</sub>)</td></tr><tr><td>Day post-challenge</td><td>2.5</td><td>4.5</td><td>6.5</td><td>8.5</td><td>10.5</td></tr><tr><td>7</td><td>77.1(75.3, 78.8)</td><td>76.7(74.9, 78.4)</td><td>76.5(74.7, 78.3)</td><td>75.9(74.1, 77.8)</td><td>74.4(72.6, 76.2)</td></tr><tr><td>14</td><td>67.4(65.4, 69.4)</td><td>66.4(64.3, 68.5)</td><td>66.0(63.9, 68.1)</td><td>64.6(62.1, 67.0)</td><td>60.7(58.8, 62.7)</td></tr><tr><td>21</td><td>56.0(53.2, 58.8)</td><td>54.3(51.2, 57.4)</td><td>53.7(50.6, 56.7)</td><td>51.3(47.7, 54.9)</td><td>45.2(42.6, 47.7)</td></tr><tr><td>28</td><td>43.9(40.0, 47.9)</td><td>41.7(37.5, 45.9)</td><td>40.9(36.8, 44.9)</td><td>37.9(33.3, 42.5)</td><td>30.5(27.4, 33.5)</td></tr></table> |
f2ff26d1a8bff9960f37d8bb67a2adb557abc65e70a4d7dc29dcd5682e1f1b44.png | simple | <table><tr><td>Parameter</td><td><i>p</i> value</td><td>HR</td><td>CI</td></tr><tr><td>Segment group (≥4)</td><td>0.0187</td><td>2.035</td><td>1.126–3.681</td></tr><tr><td>Age</td><td>0.0002</td><td>1.061</td><td>1.029–1.095</td></tr><tr><td>LVEF</td><td>0.0063</td><td>0.969</td><td>0.948–0.991</td></tr><tr><td>Gender (Female)</td><td>0.1811</td><td>1.545</td><td>0.817–2.922</td></tr><tr><td>Peripheral artery disease(PAD)</td><td>0.2651</td><td>1.483</td><td>0.742–2.965</td></tr><tr><td>Glomerular filtration rate(GFR)</td><td>0.0132</td><td>0.989</td><td>0.967–0.996</td></tr></table> |
338275587fcaaf2d2813a4011c56263b33f500ea762008fd1ac0fe97ee27f25f.png | complex | <table><tr><td rowspan="2">Correlation Coefficients</td><td colspan="8">Thermometers</td></tr><tr><td>A</td><td>B</td><td>C</td><td>D</td><td>E</td><td>F</td><td>G</td><td>H</td></tr><tr><td>A</td><td>0</td><td>0.939</td><td>0.938</td><td>0.913</td><td>0.938</td><td>0.912</td><td>0.935</td><td>0.942</td></tr><tr><td>B</td><td>0.939</td><td>0</td><td>0.781</td><td>0.888</td><td>0.898</td><td>0.902</td><td>0.913</td><td>0.739</td></tr><tr><td>C</td><td>0.938</td><td>0.781</td><td>0</td><td>0.876</td><td>0.633</td><td>0.242</td><td>0.824</td><td>0.916</td></tr><tr><td>D</td><td>0.913</td><td>0.888</td><td>0.876</td><td>0</td><td>0.924</td><td>0.831</td><td>0.904</td><td>0.647</td></tr><tr><td>E</td><td>0.938</td><td>0.898</td><td>0.633</td><td>0.924</td><td>0</td><td>0.733</td><td>0.412</td><td>0.231</td></tr><tr><td>F</td><td>0.912</td><td>0.902</td><td>0.242</td><td>0.831</td><td>0.733</td><td>0</td><td>0.647</td><td>0.750</td></tr><tr><td>G</td><td>0.935</td><td>0.913</td><td>0.824</td><td>0.904</td><td>0.412</td><td>0.647</td><td>0</td><td>0.932</td></tr><tr><td>H</td><td>0.942</td><td>0.739</td><td>0.916</td><td>0.647</td><td>0.231</td><td>0.750</td><td>0.932</td><td>0</td></tr></table> |
d7a577db3d54accc950504c3bca01de9c86a44cfb5c8cc4171e8c4202b1e6f27.png | simple | <table><tr><td>Reduction Method</td><td>Raman (ID/IG)</td><td>H (%)</td><td>Reference</td></tr><tr><td>Mg/HCl</td><td>1.52</td><td>10.3</td><td>[38]</td></tr><tr><td>Fe/HCl</td><td>1.38</td><td>9.8</td><td>[35]</td></tr><tr><td>Zn/HCl </td><td>1.49</td><td>29.6 </td><td>[36]</td></tr><tr><td>Al/HCl</td><td>1.32</td><td>7.2 </td><td>[38]</td></tr><tr><td>NH<sub>3</sub>BH<sub>3</sub>/Fe<sub>2</sub>O<sub>3</sub></td><td>1.19</td><td>43.6</td><td>this paper</td></tr></table> |
7d5d7913a324d4f5d113686e61f3184a812b07ad5f58e172474102fce162c08c.png | simple | <table><tr><td></td><td>Mean ± SD</td></tr><tr><td>Age (years)</td><td>7.99 ± 1.55</td></tr><tr><td>Mother's educational level (years)</td><td>4.51 ± 1.43</td></tr><tr><td>Weight (kg)</td><td>27.63 ± 8.26</td></tr><tr><td>Height (cm)</td><td>126.28 ± 9.93</td></tr><tr><td>BMI‐for‐age (<i>Z</i>‐Score)</td><td>0.31 ± 1.31</td></tr><tr><td>Height‐for‐age (<i>Z</i>‐Score)</td><td>‐1.23 ± 1.22</td></tr><tr><td>Percentage body fat</td><td>29.12 ± 6.68</td></tr><tr><td>Stool leukocytes (CPF)</td><td>2.36 ± 1.52</td></tr><tr><td>C‐Reactive Protein (mg/L)</td><td>0.97 ± 1.60</td></tr><tr><td>Interleukin 6 (pg/mL)</td><td>3.12 ± 3.95</td></tr><tr><td>Interleukin 10 (pg/mL)</td><td>4.33 ± 6.82</td></tr><tr><td>Tumour necrosis factor‐α (pg/mL)</td><td>4.25 ± 2.87</td></tr></table> |
cd182fe912b2b915d48ee0bc6538ce55f1ae5a98953a0c6c156c88aa1caf95ae.png | complex | <table><tr><td></td><td colspan="8">Serum</td></tr><tr><td></td><td>Total Ca</td><td>Ca<sup>2+</sup></td><td>PTH</td><td>P<sub><i>i</i></sub></td><td>ALP</td><td>BAP</td><td>Osteocalcin</td><td>TRACP-5b</td></tr><tr><td>Age (mos.)</td><td>(normal 8.9–10.2 mg/dL)</td><td>(normal 4.7–5.3 mg/dL)</td><td>(normal 4–52 pg/mL)</td><td>(normal 3.4–5.9 mg/dL)</td><td>(normal 157–477 IU/L)</td><td>(normal 88–247 U/L)</td><td>(normal 37–119 ng/mL)</td><td>(normal 13–23 U/L)</td></tr><tr><td>11</td><td>10.1</td><td>5.3</td><td>34</td><td>4.7</td><td>213</td><td>—</td><td>9</td><td>8</td></tr><tr><td>23</td><td>10.2</td><td>5.2</td><td>33</td><td>5.0</td><td>162</td><td>—</td><td>2</td><td>—</td></tr><tr><td>25</td><td>9.1</td><td>4.9</td><td>120</td><td>4.5</td><td>210</td><td>85</td><td>12</td><td>2</td></tr><tr><td>27*</td><td>10.1</td><td>—</td><td>7</td><td>5.2</td><td>125</td><td>—</td><td>—</td><td>—</td></tr><tr><td>30*</td><td>10.0</td><td>—</td><td>38</td><td>4.6</td><td>140</td><td>—</td><td>—</td><td>—</td></tr><tr><td>35</td><td>9.9</td><td>5.0</td><td>62</td><td>4.2</td><td>136</td><td>41</td><td>12</td><td>3</td></tr><tr><td>44*</td><td>9.8</td><td>5.0</td><td>22</td><td>4.4</td><td>176</td><td>63</td><td>6</td><td>3</td></tr></table> |
8dbe6c45daade01d6a4d6e69de7e97d3d7fe748af19c5cb60d8a27b7b28115b0.png | simple | <table><tr><td>Gene ID</td><td>Gene symbol</td><td>Fold change</td><td>Description</td></tr><tr><td>180579</td><td>vang-1</td><td>0.45</td><td>Vang-like protein</td></tr><tr><td>3565956</td><td>R04A9.7</td><td>0.37</td><td>Hypothetical protein</td></tr><tr><td>174941</td><td>cyd-1</td><td>0.41</td><td>G1/S-specific cyclin-D</td></tr><tr><td>179100</td><td>fat-7</td><td>0.23</td><td>Delta(9)-fatty-acid desaturase fat-7</td></tr><tr><td>178840</td><td>skr-7</td><td>0.38</td><td>SKp1 related (ubiquitin ligase complex component)</td></tr><tr><td>178495</td><td>skr-8</td><td>0.33</td><td>SKp1 related (ubiquitin ligase complex component)</td></tr><tr><td>178494</td><td>skr-9</td><td>0.27</td><td>SKp1 related (ubiquitin ligase complex component)</td></tr><tr><td>191169</td><td>kgb-2</td><td>2.03</td><td>Mitogen-activated protein kinase</td></tr><tr><td>353420</td><td>gsto-2</td><td>2.14</td><td>Probable glutathione transferase omega-2</td></tr><tr><td>180148</td><td>skr-5</td><td>2.31</td><td>SKp1 related (ubiquitin ligase complex component)</td></tr></table> |
1edd2f77c2b57358896fa5d87fc052aaa767328e45325e6167a204753a984e02.png | simple | <table><tr><td>Number of Cases by Mucormycetes</td><td>2010</td><td>2011</td><td>2012</td><td>2013</td><td>2014</td><td>Total</td></tr><tr><td><i>Apophysomyces elegans</i></td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td><i>Apophysomyces variabilis</i></td><td>5</td><td>2</td><td>-</td><td>4</td><td>1</td><td>12</td></tr><tr><td><i>Lichtheimia corymbifera</i></td><td>-</td><td>-</td><td>1</td><td>-</td><td>-</td><td>1</td></tr><tr><td><i>Lichtheimia ramosa</i></td><td>5</td><td>-</td><td>-</td><td>2</td><td>-</td><td>7</td></tr><tr><td><i>Mucor irregularis</i></td><td>-</td><td>-</td><td>-</td><td>1</td><td>-</td><td>1</td></tr><tr><td><i>Rhizopus arrhizus</i></td><td>4</td><td>4</td><td>5</td><td>2</td><td>2</td><td>17</td></tr><tr><td><i>Rhizopus microsporus</i></td><td>1</td><td>1</td><td>1</td><td>3</td><td>3</td><td>9</td></tr><tr><td><i>Rhizopus homothallicus</i></td><td>1</td><td>-</td><td>-</td><td>1</td><td>-</td><td>2</td></tr><tr><td><i>Rhizomucor pusillus</i></td><td>-</td><td>1</td><td>-</td><td>-</td><td>-</td><td>1</td></tr><tr><td><i>Saksenaea erythrospora</i></td><td>-</td><td>-</td><td>-</td><td>1</td><td>4</td><td>5</td></tr><tr><td><i>Syncephalastrum racemosum</i></td><td>-</td><td>-</td><td>-</td><td>2</td><td>2</td><td>4</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>60</td></tr></table> |
cbdff195490855e7abe21e0184798e2d2f948ffc205bf34a65e28eb7e82ed1d9.png | complex | <table><tr><td>Scientific literature</td><td>Quantitative data from the study communities</td><td>Qualitative data from local people in this study</td></tr><tr><td colspan="3">Importance of Dietary Diversity</td></tr><tr><td>• DD associated with overall food consumption, energy intake and satiety [51, 64–69]• DD associated with dietary quality, nutrient intake, nutrient density (likely explaining links to child growth and other anthropometric and biochemical markers of nutrition) [68–71]</td><td>• DD associated with overall energy intake [46]• DD associated with intake of most nutrients and nutrient adequacy (Mean Adequacy Ratio, MAR) [46]• After controlling for energy intake, DD no longer associated with intake of most nutrients [46]</td><td>• DD important for appetite and enjoyment of food• DD important because “each food has its own value”</td></tr><tr><td colspan="3">Drivers of Dietary Diversity</td></tr><tr><td>• DD linked to agrobiodiversity in at least seven studies [46, 52, 72–78],• DD associated with forest cover in three studies [47, 52, 79, 80].• DD linked to vegetable production [81]• DD linked to home gardens [52, 82]• Season may increase/decrease DD [83, 84]• Wild food use associated with higher DD [54]• DD also associated with wealth, household size, education and other economic and demographic variables</td><td>• DD associated with agrobiodiversity (crop diversity) [46]• DD associated with forest cover [46, 47].• No differences in DD between wet and dry season, but difference in sources of foods [46, 48]• DD associated with wealth and market access but not with sex or education of the head of the household (unpublished data from the study) [46]</td><td>• Agriculture, agrobiodiversity• Land use diversity/landscape heterogeneity• Different foods eaten seasonally• Wealth, available cash, land tenure• Livelihood diversity• Family size• Gender• Personality, family tradition, taboos</td></tr></table> |
ce315c044105ccd8e81e172b91337459a9a058d0a43281f95788fc8311d4cfb8.png | complex | <table><tr><td></td><td colspan="4">Cross-sectional study sample</td><td colspan="4">Longitudinal study sample</td></tr><tr><td></td><td colspan="2">Men</td><td colspan="2">Women</td><td colspan="2">Men</td><td colspan="2">Women</td></tr><tr><td></td><td>Former</td><td>Current</td><td>Former</td><td>Current</td><td>Former</td><td>Current</td><td>Former</td><td>Current</td></tr><tr><td>Age when smoking start</td><td>18.9 (4.0)</td><td>19.2 (5.3)</td><td>23.2 (7.4)</td><td>24.1 (9.5)</td><td>18.7 (4.0)</td><td>19.4 (5.9)</td><td>23.2 (7.6)</td><td>21.6 (7.8)</td></tr><tr><td>Age when smoking quit</td><td>46.3 (13.0)</td><td>n.a.</td><td>46.9 (13.6)</td><td>n.a.</td><td>46.1 (12.5)</td><td>n.a.</td><td>47.3 (14.1)</td><td>n.a.</td></tr><tr><td>Years of smoking</td><td>27.4 (13.3)</td><td>51.1 (12.5)</td><td>23.7 (14.0)</td><td>48.2 (10.4)</td><td>27.3 (12.7)</td><td>52.4 (7.0)</td><td>24.1 (14.2)</td><td>50.6 (8.9)</td></tr><tr><td>Years free of smoking</td><td>25.9 (12.5)</td><td>n.a.</td><td>25.1 (13.8)</td><td>n.a.</td><td>26.0 (12.4)</td><td>n.a.</td><td>24.5 (13.8)</td><td>n.a.</td></tr><tr><td>Smoked pack-years</td><td>21.4 (18.4)</td><td>35.6 (20.2)</td><td>15.2 (23.5)</td><td>29.0 (18.8)</td><td>21.5 (12.5)</td><td>33.5 (21.7)</td><td>15.3 (24.3)</td><td>29.3 (17.3)</td></tr></table> |
3fdbd28c10132cddf9db9793a8c0e32348f48a2bf34b8b24f383bf9f48942695.png | complex | <table><tr><td></td><td colspan="3">Sensitivity (95% CI), %</td><td colspan="3">Specificity (95% CI), %</td></tr><tr><td>Reference Criterion</td><td>Rev 1</td><td>Rev 2</td><td>Rev 3</td><td>Rev 1</td><td>Rev 2</td><td>Rev 3</td></tr><tr><td>Diagnosis</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Malignant (<i>n </i>= 16)</td><td>100 (81,100)</td><td>69 (44,86)</td><td>69 (44,86)</td><td>...</td><td>...</td><td>...</td></tr><tr><td> Benign (<i>n </i>= 32)</td><td>...</td><td>...</td><td>...</td><td>97 (84,99)</td><td>94 (80,98)</td><td>97 (84,99)</td></tr><tr><td>Mass</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Present (<i>n </i>= 38)</td><td>97 (87,100)</td><td>97 (87,100)</td><td>97 (87,100)</td><td>...</td><td>...</td><td>...</td></tr><tr><td> Absent (<i>n </i>= 10)</td><td>...</td><td>...</td><td>...</td><td>90 (60,98)</td><td>80 (49,94)</td><td>100 (72,100)</td></tr><tr><td>Calcification</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Present (<i>n </i>= 25)</td><td>72 (52,86)</td><td>40 (23,59)</td><td>60 (41,77)</td><td>...</td><td>...</td><td>...</td></tr><tr><td> Absent (<i>n </i>= 23)</td><td>...</td><td>...</td><td>...</td><td>83 (63,93)</td><td>87 (68,95)</td><td>87 (68,95)</td></tr></table> |
5abd7955e6db2d29202eb73239689084ef59dd68dc8fd9413d813f003d1c3626.png | simple | <table><tr><td>Scales</td><td>Secure</td><td>Fearful</td><td>Preoccupied</td><td>Dismissing</td></tr><tr><td> Cronbach’s alpha </td><td> 0.630 </td><td> 0.766 </td><td> 0.723 </td><td> 0.588 </td></tr></table> |
2b597738896bf9709f86bb893a6d311bf9f1c6a7da016251d916b2b734bc1df7.png | simple | <table><tr><td>Alcohol/Cannabis Pairs</td><td>Mean</td><td>SD</td><td>Relevant t values</td></tr><tr><td>All Alcohol Per Month</td><td>M = 42.4</td><td>SD = 55.4</td><td>t(2573) = 24.0**</td></tr><tr><td>Only Alcohol Per Month</td><td>M = 20.47</td><td>SD = 42.3</td><td></td></tr><tr><td>All Alcohol Per Month</td><td>M = 42.4</td><td>SD = 55.4</td><td>t(2574) = 16.3**</td></tr><tr><td>Simultaneous Drinks Per Month</td><td>M = 28.7</td><td>SD = 49.4</td><td></td></tr><tr><td>Only Alcohol Per Month</td><td>M = 20.47</td><td>SD = 42.3</td><td>t(2558) = 8.1**</td></tr><tr><td>Simultaneous Drinks Per Month</td><td>M = 28.7</td><td>SD = 49.4</td><td></td></tr><tr><td>All Cannabis Per Month</td><td>M = 2.8</td><td>SD = 1.5</td><td>t(2585) = 3.4**</td></tr><tr><td>Only Cannabis Per Month</td><td>M = 2.6</td><td>SD = 1.3</td><td></td></tr><tr><td>All Cannabis Per Month</td><td>M = 2.8</td><td>SD = 1.5</td><td>t(2572) = 32.4**</td></tr><tr><td>Simultaneous Cannabis Per Month</td><td>M = 1.9</td><td>SD = 1.3</td><td></td></tr><tr><td>Only Cannabis Per Month</td><td>M = 2.6</td><td>SD = 1.3</td><td>t(2543) = 29.4**</td></tr><tr><td>Simultaneous Cannabis Per Month</td><td>M = 1.9</td><td>SD = 1.3</td><td></td></tr></table> |
531442e4782f99e0bfcbf09c5c37eff5267bacda5e676d99c3570034be878098.png | complex | <table><tr><td> </td><td colspan="2">Peanut (n = 29)</td><td colspan="2">Control (n = 28)</td><td><i>P </i>value<sup>a</sup></td></tr><tr><td>Nutrient</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td> </td></tr><tr><td>Energy, kcal</td><td>1599</td><td>397</td><td>1598</td><td>443</td><td>0.99</td></tr><tr><td>Total carbohydrate, g</td><td>174</td><td>43</td><td>189</td><td>56</td><td>0.28</td></tr><tr><td>Total protein, g</td><td>74</td><td>19</td><td>71</td><td>20</td><td>0.53</td></tr><tr><td>Total fat, g</td><td>72</td><td>26</td><td>65</td><td>24</td><td>0.29</td></tr><tr><td> SFA, g</td><td>20</td><td>8</td><td>22</td><td>9</td><td>0.26</td></tr><tr><td> MUFA, g</td><td>30</td><td>11</td><td>24</td><td>10</td><td>0.04</td></tr><tr><td> PUFA, g</td><td>17</td><td>6</td><td>13</td><td>5</td><td><0.01</td></tr><tr><td>PUFA:SFA (P:S) ratio</td><td>1.01</td><td>0.27</td><td>0.72</td><td>0.27</td><td><0.01</td></tr><tr><td>Cholesterol, mg</td><td>210</td><td>143</td><td>270</td><td>136</td><td>0.11</td></tr><tr><td>Fiber, g</td><td>22</td><td>6</td><td>19</td><td>7</td><td>0.19</td></tr><tr><td>Vitamin C, mg</td><td>83</td><td>46</td><td>71</td><td>33</td><td>0.28</td></tr><tr><td>Vitamin D, μg</td><td>3.4</td><td>2.3</td><td>3.6</td><td>1.6</td><td>0.81</td></tr><tr><td>α-tocopherol equivalents, mg</td><td>11.8</td><td>4.3</td><td>9.1</td><td>4.4</td><td>0.02</td></tr><tr><td>Niacin, mg</td><td>23.5</td><td>6.5</td><td>20.0</td><td>5.9</td><td>0.03</td></tr><tr><td>Folate, μg</td><td>402</td><td>119</td><td>385</td><td>122</td><td>0.58</td></tr><tr><td>Vitamin B12, μg</td><td>5.6</td><td>7.4</td><td>4.3</td><td>1.7</td><td>0.36</td></tr><tr><td>Calcium, mg</td><td>703</td><td>292</td><td>763</td><td>286</td><td>0.42</td></tr><tr><td>Phosphorus, mg</td><td>1114</td><td>263</td><td>1092</td><td>303</td><td>0.77</td></tr><tr><td>Magnesium, mg</td><td>302</td><td>53</td><td>245</td><td>68</td><td><0.01</td></tr><tr><td>Copper, mg</td><td>9.8</td><td>2.4</td><td>10.3</td><td>3.6</td><td><0.01</td></tr><tr><td>Sodium, mg</td><td>2703</td><td>817</td><td>2973</td><td>855</td><td>0.22</td></tr><tr><td>Potassium, mg</td><td>2557</td><td>550</td><td>2298</td><td>647</td><td>0.10</td></tr></table> |
f8c7e63cc0a104f9d34f86db32a04f4db6ea2885a8b5b521b4b08028c781e893.png | complex | <table><tr><td>Proportion of words on inventory</td><td colspan="7">Number of words in production vocabulary (N)</td></tr><tr><td></td><td>1–5 (82)</td><td>6–10 (35)</td><td>11–20 (41)</td><td>21–50 (16)</td><td>1-50 (174)</td><td>51+ (15)</td><td>Total</td></tr><tr><td>Nominals</td><td>0.01</td><td>0.04</td><td>0.07</td><td>0.14</td><td>0.04</td><td>0.44</td><td>0.07</td></tr><tr><td>Common nouns</td><td>0.00</td><td>0.01</td><td>0.02</td><td>0.08</td><td>0.01</td><td>0.41</td><td>0.05</td></tr><tr><td>People</td><td>0.12</td><td>0.21</td><td>0.29</td><td>0.42</td><td>0.21</td><td>0.60</td><td>0.24</td></tr><tr><td>Sound effects</td><td>0.03</td><td>0.20</td><td>0.31</td><td>0.38</td><td>0.16</td><td>0.47</td><td>0.19</td></tr><tr><td>Routines</td><td>0.01</td><td>0.05</td><td>0.10</td><td>0.17</td><td>0.06</td><td>0.44</td><td>0.09</td></tr><tr><td>Predicates</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.02</td><td>0.00</td><td>0.25</td><td>0.02</td></tr><tr><td>Verbs</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.01</td><td>0.00</td><td>0.24</td><td>0.02</td></tr><tr><td>Adjectives</td><td>0.00</td><td>0.00</td><td>0.00</td><td>0.04</td><td>0.01</td><td>0.31</td><td>0.03</td></tr><tr><td>Function words</td><td>0.00</td><td>0.00</td><td>0.01</td><td>0.13</td><td>0.01</td><td>0.38</td><td>0.04</td></tr></table> |
be56e11af558f069c83c8437496d2ee4ae905ee39b014e402697bd250cfbd2fc.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="3">Univariate</td><td colspan="3">Multivariate</td></tr><tr><td colspan="2">HR (95 % CI)</td><td><i>p</i>-value</td><td colspan="2">HR (95 % CI)</td><td><i>p</i>-value</td></tr><tr><td>Age (≥70)</td><td>0.97</td><td>(0.85–1.11)</td><td>0.68</td><td>0.98</td><td>(0.79–1.23)</td><td>0.87</td></tr><tr><td>Gender (female)</td><td>1.04</td><td>(0.35–3.07)</td><td>0.95</td><td>1.06</td><td>(0.33–3.44)</td><td>0.92</td></tr><tr><td>Urine cytology before the initial TUR (suspicious positive and positive)</td><td>1.52</td><td>(0.44–5.22)</td><td>0.50</td><td>1.77</td><td>(0.48–6.54)</td><td>0.39</td></tr><tr><td>Tumor size (≥3 cm)</td><td>1.95</td><td>(0.84–4.53)</td><td>0.12</td><td>2.73</td><td>(1.07–7.00)</td><td>0.03<sup>*</sup></td></tr><tr><td>Tumor number (multiple)</td><td>0.62</td><td>(0.27–1.45)</td><td>0.27</td><td>0.94</td><td>(0.37–2.38)</td><td>0.89</td></tr><tr><td>Concomitant CIS (existence)</td><td>1.23</td><td>(0.29–5.25)</td><td>0.78</td><td>3.21</td><td>(0.62–16.67)</td><td>0.17</td></tr><tr><td>BCG induction instillation (without)</td><td>0.28</td><td>(0.12–0.67)</td><td><0.01<sup>**</sup></td><td>0.20</td><td>(0.07–0.57)</td><td><0.01<sup>**</sup></td></tr></table> |
a195d23b59094552b249692325d227e0f56fb7f8822167d2cdd3d88cf2677027.png | simple | <table><tr><td>Score</td><td>Histological features of seminiferous tubules</td><td>Remark</td></tr><tr><td>0</td><td>Orderly arrangement of germinal cells with plenty of sperm and spermatids</td><td>Normal</td></tr><tr><td>I</td><td>Preservation of germ cell layers with decrease of sperm and spermatids </td><td>Mild injury</td></tr><tr><td>II</td><td>Disarray and decrease of germ cell layers with loss of sperm and spermatids </td><td>Moderate injury</td></tr><tr><td>III</td><td>Absence of germ cell layers </td><td>Severe injury</td></tr></table> |
2b9ed2ee60c4cf07e9df1782741b7caa4f8ee97dddc6cf6999f3352523832d40.png | simple | <table><tr><td> </td><td>Checklist</td></tr><tr><td>1</td><td>Are you often thirsty?</td></tr><tr><td>2</td><td>Do you produce urine frequently?</td></tr><tr><td>3</td><td>Are you worried about urinary smell?</td></tr><tr><td>4</td><td>Do you feel numbness of your extremities?</td></tr><tr><td>5</td><td>Do you have edema in your legs?</td></tr><tr><td>6</td><td>Do you have cramps in your legs?</td></tr><tr><td>7</td><td>Are you insensitive to the pain of a small wound or burn?</td></tr><tr><td>8</td><td>Do you have a feeling of listlessness?</td></tr><tr><td>9</td><td>Do you feel lightheaded?</td></tr><tr><td>10</td><td>Is your vision blurry? Is your eyesight getting worse?</td></tr></table> |
808148741ed749c14b077d0c0edae91295b9a8eed95aba72e69ecce2de870641.png | complex | <table><tr><td></td><td colspan="3">Total protein (mg)</td><td colspan="3">% of solubilization</td></tr><tr><td>Process Step</td><td>Exp #1</td><td>Exp #2</td><td>Exp #3</td><td>Exp #1</td><td>Exp #2</td><td>Exp #3</td></tr><tr><td>Supernatant 4 M urea wash</td><td>1015.2</td><td>92.3</td><td>246</td><td>NE</td><td>NE</td><td>NE</td></tr><tr><td>Pellet 4 M urea wash</td><td>1045.2</td><td>378</td><td>740</td><td>NE</td><td>NE</td><td>NE</td></tr><tr><td>Supernatant 8 M urea solubilization</td><td>905.8</td><td>264</td><td>589</td><td>86</td><td>69.8</td><td>79.5</td></tr><tr><td>Pellet 8 M urea solubilization</td><td>24</td><td>16.5</td><td>23</td><td>NE</td><td>NE</td><td>NE</td></tr></table> |
ac88863fba3b92c8abebb471773f4f673740f121f59b9bd40a75e71957471c1d.png | complex | <table><tr><td>First author (ref)</td><td colspan="2">Number of subjects with depression</td><td colspan="2">Number of subjects without depression</td><td>Total numbers of subjects</td><td>Crude RR (95% CI)</td><td>Multivariable Adjusted RR (95% CI) reported in paper</td><td>Adjustment factors for multivariable RR</td></tr><tr><td></td><td>Cancer</td><td>No cancer</td><td>Cancer</td><td>No Cancer</td><td></td><td></td><td></td><td></td></tr><tr><td>Kaplan (8)</td><td>117</td><td>N.a.</td><td>612</td><td>N.a.</td><td>6,848</td><td>-</td><td>0.97 males 1.27 females</td><td>Age, sex</td></tr><tr><td>Zonderman (10)</td><td>110</td><td>892</td><td>527</td><td>4,874</td><td>6,403</td><td>1.13 (0.93–1.37)</td><td>1.1 (0.9–1.4)</td><td>Age, sex, marital status, smoking, family history of cancer, hypertension, cholesterol level</td></tr><tr><td>Linkins (11)</td><td>25</td><td>343</td><td>144</td><td>1,752</td><td>2,264</td><td>0.89 (0.59–1.35)</td><td>1.09 (0.69–1.71)</td><td>Age</td></tr><tr><td>Vogt (20)</td><td>N.a.</td><td>N.a.</td><td>N.a.</td><td>N.a.</td><td>1,529</td><td>1.08 (0.79–1.49)</td><td>1.08 (0.77–1.52)</td><td>Age, sex, social class, Smoking, duration of health plan membership</td></tr><tr><td>Knekt (17)</td><td>29</td><td>295</td><td>486</td><td>5,298</td><td>7,018</td><td>1.07 (0.75–1.52)</td><td>0.99 (0.68–1.44)</td><td>Age, sex</td></tr><tr><td>Penninx (19)</td><td>16</td><td>130</td><td>386</td><td>4293</td><td>4825</td><td>1.33 (0.83–2.13)</td><td>1.88 (1.13–3.14)</td><td>Age, sex, race, disability, hospital admissions, alcohol, smoking</td></tr><tr><td>Gallo (15)</td><td>8</td><td>82</td><td>141</td><td>1,338</td><td>1,569</td><td>0.93 (0.47–1.84)</td><td>1.3 (0.6–2.8)</td><td>Age, sex, smoking, alcohol</td></tr><tr><td>van den Heuvel (22)</td><td>9</td><td>207</td><td>67</td><td>2,059</td><td>2,342</td><td>1.32 (0.67–2.61)</td><td>n.a.</td><td></td></tr><tr><td>Schuurman (23)</td><td>95</td><td>1,246</td><td>3,369</td><td>63,656</td><td>68,366</td><td>1.41 (1.16–1.72)</td><td>1.08 (0.88–1.33)</td><td>Age, sex, socioeconomic status</td></tr></table> |
089080368790060c42cb8adb2d42e0471951c6bbcc45bee7fef52789c3c705c4.png | complex | <table><tr><td> </td><td colspan="2">Induction</td><td colspan="2">Repression</td></tr><tr><td> </td><td>Range of SLR (significant to max.)</td><td>Number of genes [% of total]</td><td>Range of SLR (min. to significant)</td><td>Number of genes [% of total]</td></tr><tr><td>Spermatocytes HS_38°C versus control</td><td>0.82 to 2.21</td><td>517 [3.53]</td><td>−2.84 to −0.82</td><td>909 [6.20]</td></tr><tr><td>Spermatocytes HS_43°C versus control</td><td>0.49 to 2.43</td><td>18 [0.12]</td><td>−1.35 to −0.36</td><td>362 [2.47]</td></tr><tr><td>Hepatocytes HS_43°C versus control</td><td>0.75 to 6.17</td><td>155 [1.07]</td><td>−3.62 to −0.75</td><td>133 [0.92]</td></tr></table> |
21fcf774dae2142b68d1164ec5ba18fb7c645badc6dd7533e2eaa3022940082b.png | complex | <table><tr><td colspan="2">Characteristic</td><td>Low Arterial Stiffness</td><td>High Arterial Stiffness</td><td><i>P</i></td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>51 (75.0)</td><td>28 (75.7)</td><td rowspan="2">0.939</td></tr><tr><td>Female</td><td>17 (25.0)</td><td>9 (24.3)</td></tr><tr><td rowspan="2">Diabetes mellitus</td><td>No</td><td>43 (63.2)</td><td>11 (29.7)</td><td rowspan="2">0.001*</td></tr><tr><td>Yes</td><td>25 (36.8)</td><td>26 (70.3)</td></tr><tr><td rowspan="2">Hypertension</td><td>No</td><td>40 (58.8)</td><td>12 (32.4)</td><td rowspan="2">0.010*</td></tr><tr><td>Yes</td><td>28 (41.2)</td><td>25 (67.6)</td></tr><tr><td rowspan="2">Angiotensin-converting enzyme inhibitor</td><td>No</td><td>53 (77.9)</td><td>29 (78.4)</td><td rowspan="2">0.959</td></tr><tr><td>Yes</td><td>15 (22.1)</td><td>8 (21.6)</td></tr><tr><td rowspan="2">Angiotensin-receptor blocker</td><td>No</td><td>50 (73.5)</td><td>27 (73.0)</td><td rowspan="2">0.951</td></tr><tr><td>Yes</td><td>18 (26.5)</td><td>10 (27.0)</td></tr><tr><td rowspan="2">β-blocker</td><td>No</td><td>36 (52.9)</td><td>20 (54.1)</td><td rowspan="2">0.913</td></tr><tr><td>Yes</td><td>32 (47.1)</td><td>17 (45.9)</td></tr><tr><td rowspan="2">Calcium-channel blocker</td><td>No</td><td>48 (70.6)</td><td>22 (59.5)</td><td rowspan="2">0.248</td></tr><tr><td>Yes</td><td>20 (29.4)</td><td>15 (40.5)</td></tr><tr><td rowspan="2">Statin</td><td>No</td><td>22 (32.4)</td><td>14 (37.8)</td><td rowspan="2">0.572</td></tr><tr><td>Yes</td><td>46 (67.6)</td><td>23 (62.2)</td></tr><tr><td rowspan="2">Fibrate</td><td>No</td><td>50 (73.5)</td><td>30 (81.1)</td><td rowspan="2">0.385</td></tr><tr><td>Yes</td><td>14 (26.5)</td><td>7 (18.9)</td></tr></table> |
239bfa585660ab83a0a36ddbe97503775a32816acbb1033500b0877869b62a53.png | complex | <table><tr><td>Level</td><td>Interviewees (data collection method)</td><td>Number of interviews /group discussions</td></tr><tr><td rowspan="3">National</td><td>Ministry of Health (interview)</td><td>3</td></tr><tr><td>UNICEF (interview)</td><td>1</td></tr><tr><td>WHO (interview)</td><td>1</td></tr><tr><td>Province</td><td>Provincial Directorate of Health, Nampula, Mozambique (interview)</td><td>2</td></tr><tr><td>District</td><td>District Community Health Managers (9 participants) (focus group)</td><td>1</td></tr><tr><td rowspan="2">Health Facilities</td><td>Health workers (interview)</td><td>8</td></tr><tr><td>Observations (2 urban health facilities and 2 rural health facilities, each of which were observed for one week)</td><td>4</td></tr><tr><td rowspan="6">Community</td><td>Mothers (interview)</td><td>8</td></tr><tr><td>Fathers (interview)</td><td>8</td></tr><tr><td>Community leaders (interview)</td><td>5</td></tr><tr><td>Community Health Workers (interview)</td><td>2</td></tr><tr><td>Women (focus groups of 6–12 participants)</td><td>3</td></tr><tr><td>Men (focus groups of 10–12 participants)</td><td>3</td></tr></table> |
d7755948a0e7727df6c338d3ee312ffca81fd25c92fffca2b8f18743f10a2c8e.png | complex | <table><tr><td></td><td>Significant Biomarkers</td><td>Physiological Processes</td></tr><tr><td rowspan="4">Asthma</td><td>Platelet Count</td><td>Thrombogenesis</td></tr><tr><td></td><td>Serum Sodium</td><td>Serum sodium</td></tr><tr><td></td><td>ALT</td><td>Tissue injury</td></tr><tr><td></td><td>Neutrophil Percent</td><td>Acute inflammation</td></tr><tr><td rowspan="4">Type 1 Diabetes</td><td>Serum Sodium</td><td>Serum sodium</td></tr><tr><td></td><td>Blood Urea Nitrogen</td><td>Kidney function</td></tr><tr><td></td><td>Platelet Count</td><td>Thrombogenesis</td></tr><tr><td></td><td>TSH3</td><td>Thyroid function</td></tr><tr><td rowspan="3">Type 2 Diabetes</td><td>Serum Sodium</td><td>Serum sodium</td></tr><tr><td></td><td>ALT</td><td>Tissue injury</td></tr><tr><td></td><td>Platelet Count</td><td>Thrombogenesis</td></tr><tr><td rowspan="4">Duchenne Muscular Dystrophy</td><td>Lactate Dehydrogenase</td><td>Tissue injury</td></tr><tr><td></td><td>Triglycerides</td><td>Lipogenesis</td></tr><tr><td></td><td>Platelet Count</td><td>Thrombogenesis</td></tr><tr><td></td><td>AST</td><td>Tissue injury</td></tr><tr><td rowspan="3">Cystic Fibrosis</td><td>Total IgE</td><td>IgE antibody response</td></tr><tr><td></td><td>Alkaline Phosphatase</td><td>Dephosphorylation</td></tr><tr><td></td><td>Platelet Count</td><td>Thrombogenesis</td></tr></table> |
1dc6adf9764247e0d62fbff08d7ea0e4221b3061860cc558eeb955a212190506.png | simple | <table><tr><td></td><td>Mean (Range)</td></tr><tr><td>Age (years)</td><td>75 (64-86)</td></tr><tr><td>Weight (lbs)</td><td>153 (116-225)</td></tr><tr><td>FEV1 (L)</td><td>1.12 (0.53-2.48)</td></tr><tr><td>% predicted FEV1</td><td>59 (21-111)</td></tr></table> |
48b2437e11119eccf5f74fae75bc94408b67ccd50e4f7e3da0ea706d8eb9bd39.png | complex | <table><tr><td>Characteristic</td><td>Levofloxacin <i>N</i> = 370</td></tr><tr><td colspan="2">Age, years</td></tr><tr><td> Mean (SD)</td><td>48.0 (20.26)</td></tr><tr><td> Range, <i>n</i> (%)</td><td>18–87</td></tr><tr><td>≥ 65–< 75</td><td>47 (12.7)</td></tr><tr><td>≥ 75</td><td>43 (11.6)</td></tr><tr><td colspan="2">Sex, <i>n</i> (%)</td></tr><tr><td> Male</td><td>82 (22.2)</td></tr><tr><td> Female</td><td>288 (77.8)</td></tr><tr><td colspan="2">Race, <i>n</i> (%)</td></tr><tr><td> White</td><td>317 (85.7)</td></tr><tr><td> Black or African American</td><td>6 (1.6)</td></tr><tr><td> Asian</td><td>30 (8.1)</td></tr><tr><td> Other</td><td>17 (4.6)</td></tr><tr><td colspan="2">Region, <i>n</i> (%)</td></tr><tr><td> Eastern Europe</td><td>277 (74.9)</td></tr><tr><td> Western Europe</td><td>0</td></tr><tr><td> North America</td><td>9 (2.4)</td></tr><tr><td> South America</td><td>39 (10.5)</td></tr><tr><td> Rest of world</td><td>45 (12.2)</td></tr><tr><td colspan="2">Diagnosis, <i>n</i> (%)</td></tr><tr><td> Pyelonephritis</td><td>306 (82.7)</td></tr><tr><td> cLUTI</td><td>64 (17.3)</td></tr><tr><td colspan="2">Creatinine clearance, mL/min, <i>n</i> (%)</td></tr><tr><td> Normal (≥80)</td><td>250 (67.6)</td></tr><tr><td> Mild impairment (≥50–< 80)</td><td>92 (24.9)</td></tr><tr><td> Moderate impairment (≥30–< 50)</td><td>27 (7.3)</td></tr><tr><td> Severe impairment (<30)</td><td>1 (0.3)</td></tr></table> |
7355734b85816508304f1ed0c0d8d0e6ec7b413b0e60370be5b407faae1c5e1a.png | complex | <table><tr><td rowspan="2">Markers of cardio-metabolic risk</td><td></td><td>Time spent in cars</td><td></td><td rowspan="2">p for trend</td></tr><tr><td>> 15 to ≤ 30 min/day (n = 749)</td><td>> 30 to ≤ 60 min/day (n = 851)</td><td>> 60 min/day (n = 673)</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>0.36 (− 0.22, 0.94)</td><td>0.56 (− 0.01, 1.12)</td><td>0.77 (0.16, 1.38)⁎</td><td>0.011</td></tr><tr><td>Waist circumference (cm)</td><td>0.75 (− 0.67, 2.16)</td><td>1.30 (− 0.08, 2.69)</td><td>1.50 (0.02, 2.98)⁎</td><td>0.034</td></tr><tr><td>Systolic BP (mmHg)a</td><td>0.69 (− 1.00, 2.37)</td><td>0.34 (− 1.32, 2.00)</td><td>1.60 (− 0.18, 3.37)</td><td>0.13</td></tr><tr><td>Diastolic BP (mmHg)a</td><td>0.56 (− 0.56, 1.68)</td><td>0.71 (− 0.39, 1.81)</td><td>0.69 (− 0.50, 1.87)</td><td>0.26</td></tr><tr><td>Triglycerides (log, mmol/L)b</td><td>0.016 (− 0.015, 0.047)</td><td>0.017 (− 0.013, 0.048)</td><td>0.002 (− 0.030, 0.035)</td><td>0.94</td></tr><tr><td>HDL-cholesterol (mmol/L)b</td><td>− 0.001 (− 0.042, 0.040)</td><td>− 0.019 (− 0.059, 0.021)</td><td>− 0.014 (− 0.057, 0.029)</td><td>0.36</td></tr><tr><td>Fasting plasma glucose (log, mmol/L)</td><td>0.005 (− 0.007, 0.017)</td><td>0.008 (− 0.004, 0.019)</td><td>0.013 (0.000, 0.026)⁎</td><td>0.044</td></tr><tr><td>2-h plasma glucose (log, mmol/L)</td><td>− 0.003 (− 0.036, 0.030)</td><td>− 0.022 (− 0.054, 0.011)</td><td>0.013 (− 0.021, 0.048)</td><td>0.72</td></tr><tr><td>Clustered cardio-metabolic riska, b</td><td>0.040 (− 0.022, 0.102)</td><td>0.062 (0.001, 0.123)⁎</td><td>0.076 (0.011, 0.141)⁎</td><td>0.017</td></tr><tr><td>Metabolic syndromec</td><td>1.07 (0.82, 1.41)</td><td>1.13 (0.86, 1.47)</td><td>0.93 (0.70, 1.24)</td><td>0.70</td></tr></table> |
d12dd58bfba161ee1752111fcd460ccab6b76fa32623c93114dedf705638db03.png | simple | <table><tr><td>Variable</td><td></td><td>At admission</td><td>1 week after admission</td><td><i>t</i><sub><i>(df)</i></sub></td><td><i>p</i></td></tr><tr><td>Improved</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Pain</td><td>163</td><td>5.49 ± 2.10</td><td>2.37 ± 1.45</td><td>21.98<sub><i>(162)</i></sub></td><td><.001*</td></tr><tr><td> Anxiety</td><td>153</td><td>2.33 ± 0.98</td><td>2.04 ± 0.92</td><td>4.36<sub><i>(152)</i></sub></td><td><.001*</td></tr><tr><td> Depression</td><td>153</td><td>2.27 ± 1.01</td><td>1.90 ± 0.97</td><td>5.97<sub><i>(152)</i></sub></td><td><.001*</td></tr><tr><td> Anger</td><td>151</td><td>1.62 ± 0.87</td><td>1.42 ± 0.76</td><td>3.52<sub><i>(150)</i></sub></td><td>.001*</td></tr><tr><td> Family support</td><td>156</td><td>4.61 ± 1.05</td><td>4.72 ± 1.01</td><td>−2.40<sub><i>(155)</i></sub></td><td>.018*</td></tr><tr><td> Social support</td><td>156</td><td>4.46 ± 1.22</td><td>4.62 ± 1.22</td><td>−3.64<sub><i>(155)</i></sub></td><td><.001*</td></tr><tr><td> Fear of death</td><td>139</td><td>2.76 ± 0.75</td><td>2.39 ± 0.79</td><td>7.44<sub><i>(138)</i></sub></td><td><.001*</td></tr><tr><td>Not improved</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Pain</td><td>74</td><td>2.20 ± 2.48</td><td>2.58 ± 2.65</td><td>−4.13<sub><i>(73)</i></sub></td><td><.001*</td></tr><tr><td> Anxiety</td><td>72</td><td>2.29 ± 0.86</td><td>2.08 ± 0.75</td><td>2.42<sub><i>(71)</i></sub></td><td>.018*</td></tr><tr><td> Depression</td><td>73</td><td>2.32 ± 1.01</td><td>2.25 ± 1.04</td><td>0.82<sub><i>(72)</i></sub></td><td>.415</td></tr><tr><td> Anger</td><td>72</td><td>1.76 ± 0.99</td><td>1.63 ± 0.88</td><td>2.44<sub><i>(71)</i></sub></td><td>.017*</td></tr><tr><td> Family support</td><td>73</td><td>4.48 ± 1.04</td><td>4.55 ± 1.00</td><td>−1.40<sub><i>(72)</i></sub></td><td>.167</td></tr><tr><td> Social support</td><td>73</td><td>4.29 ± 1.22</td><td>4.37 ± 1.11</td><td>−1.10<sub><i>(72)</i></sub></td><td>.276</td></tr><tr><td> Fear of death</td><td>68</td><td>2.79 ± 0.78</td><td>2.60 ± 0.79</td><td>2.14<sub><i>(67)</i></sub></td><td>.036*</td></tr></table> |
a2f9babe1293a78fcb231ab77e3fc679755633dc09422a6b645b349b96469902.png | complex | <table><tr><td></td><td>HIV status by verbal autopsy classification</td><td>Total (%)</td><td colspan="2">True HIV serostatus</td></tr><tr><td></td><td></td><td></td><td>HIV-positive</td><td>HIV-negative</td></tr><tr><td>13-44 years</td><td>Positive</td><td>44 (50.6%)</td><td>32</td><td>12</td></tr><tr><td></td><td>Negative</td><td>32 (36.8%)</td><td>2</td><td>30</td></tr><tr><td></td><td>Don't know</td><td>11 (12.6%)</td><td>2</td><td>9</td></tr><tr><td></td><td></td><td>87 (100%)</td><td>36 (41.4%)</td><td>51 (58.6%)</td></tr><tr><td>45-64 years</td><td>Positive</td><td>18 (30.5%)</td><td>14</td><td>4</td></tr><tr><td></td><td>Negative</td><td>35 (59.3%)</td><td>4</td><td>31</td></tr><tr><td></td><td>Don't know</td><td>6 (10.2%)</td><td>1</td><td>5</td></tr><tr><td></td><td></td><td>59 (100%)</td><td>19 (32.2%)</td><td>40 (67.8%)</td></tr><tr><td>65+ years</td><td>Positive</td><td>6 (5.1%)</td><td>2</td><td>4</td></tr><tr><td></td><td>Negative</td><td>103 (87.3%)</td><td>1</td><td>102</td></tr><tr><td></td><td>Don't know</td><td>9 (7.6%)</td><td>1</td><td>8</td></tr><tr><td></td><td></td><td>118 (100%)</td><td>4 (3.4%)</td><td>114 (96.6%)</td></tr><tr><td>All ages</td><td>Positive</td><td>68 (25.8%)</td><td>48</td><td>20</td></tr><tr><td></td><td>Negative</td><td>170 (64.4%)</td><td>7</td><td>163</td></tr><tr><td></td><td>Don't know</td><td>26 (9.8%)</td><td>4</td><td>22</td></tr><tr><td>Total deaths</td><td></td><td>264 (100%)</td><td>59 (22.3%)</td><td>205 (77.7%)</td></tr></table> |
37fb6f6fb5bbca2eb9ed049dcb755232d8b349e96301cc4412ca0adcd613d5d5.png | simple | <table><tr><td>Characteristic</td><td>Group 1 (<i>n</i> = 26)</td><td>Group 2 (<i>n</i> = 7)</td></tr><tr><td>Urine culture</td><td> </td><td> </td></tr><tr><td> <i>Escherichia coli</i> (%)</td><td>15 (%57)</td><td>5 (%71)</td></tr><tr><td>Quinolone resistance (%)</td><td>10 (%66.6)</td><td>4 (%80)</td></tr><tr><td>ESBL (%)</td><td>6 (%40)</td><td>3 (%60)</td></tr><tr><td>Blood culture</td><td> </td><td> </td></tr><tr><td> <i>Escherichia coli</i> (%)</td><td>5 (%19)</td><td>0</td></tr><tr><td>Quinolone resistance (%)</td><td>5 (%100)</td><td>0</td></tr><tr><td>ESBL (%)</td><td>4 (%80)</td><td>0</td></tr></table> |
18bfb47cdfa40c950b98735ec3557aa28df1d99cd3eecaf63f8ea5bbf30c67ab.png | simple | <table><tr><td></td><td>NB</td><td><i>k</i>-NN</td><td>SVM</td><td>RF</td></tr><tr><td>Balanced accuracy (%)</td><td>70.2</td><td>74.1</td><td>81.6</td><td>87.8</td></tr><tr><td>Sensitivity (%)</td><td>62.0</td><td>74.0</td><td>78.7</td><td>89.4</td></tr><tr><td>Specificity (%)</td><td>78.4</td><td>74.2</td><td>84.2</td><td>85.9</td></tr></table> |
3831b68d4b6367079565946607c81b15ce4639bec72808bc45364f3bb9ab2381.png | complex | <table><tr><td>Variable entered</td><td colspan="3">Models</td></tr><tr><td></td><td>1</td><td>2</td><td>3</td></tr><tr><td>Intention</td><td>.51***</td><td>.37***</td><td>.49***</td></tr><tr><td>Past behaviour</td><td>.44***</td><td>.43***</td><td>.44***</td></tr><tr><td>PBC</td><td>.10</td><td>.08</td><td>.09</td></tr><tr><td>Age</td><td></td><td>.12</td><td></td></tr><tr><td>Intention × Age</td><td></td><td>.11</td><td></td></tr><tr><td>Annual income</td><td></td><td>-.11</td><td>-.06</td></tr><tr><td>PBC × annual income</td><td></td><td>.20**</td><td>.24***</td></tr><tr><td>R<sup>2</sup></td><td>.44</td><td>.47</td><td>.46</td></tr><tr><td>Model F</td><td>77.57***</td><td>37.23***</td><td>50.78***</td></tr><tr><td>ΔR<sup>2</sup></td><td>-</td><td>.03</td><td>.02</td></tr><tr><td>ΔF</td><td>-</td><td>4.69***</td><td>7.05***</td></tr></table> |
0b486bebb0b97b877fc3902fbb843b8fbe89b1c2da3a44eab1f190f390ca44f7.png | complex | <table><tr><td rowspan="2">Approach</td><td colspan="10">Number of Links</td></tr><tr><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td><td>All</td></tr><tr><td>ELM</td><td>0.3406</td><td>0.2324</td><td>0.0615</td><td>0.2463</td><td>0.4031</td><td>0.2074</td><td>0.4060</td><td>0.0694</td><td>0.2941</td><td>0.5155</td></tr><tr><td>WKNN</td><td>0.8250</td><td>0.2361</td><td>0.5011</td><td>0.5230</td><td>0.4441</td><td>0.4998</td><td>0.2007</td><td>0.2752</td><td>0.5125</td><td>0.5731</td></tr><tr><td>SVM</td><td>0.2107</td><td>0.6580</td><td>0.3419</td><td>0.0975</td><td>0.0285</td><td>0.0228</td><td>0.0937</td><td>0.1999</td><td>0.1014</td><td>0.2828</td></tr><tr><td>BPNN</td><td>0.6642</td><td>0.4730</td><td>0.4369</td><td>0.8897</td><td>0.6539</td><td>0.3722</td><td>0.2866</td><td>0.7086</td><td>0.7951</td><td>0.4424</td></tr></table> |
9d64e214a1f23198248c383c824e9f28b2f36dc5c126c1f613b549d1874e1036.png | simple | <table><tr><td>Variable</td><td><i>n</i></td><td>%</td></tr><tr><td>Gender</td><td> </td><td> </td></tr><tr><td> Male</td><td>30</td><td>53.6</td></tr><tr><td> Female</td><td>26</td><td>46.4</td></tr><tr><td>Age (years)</td><td> </td><td> </td></tr><tr><td> <40</td><td>30</td><td>53.6</td></tr><tr><td> ≥40</td><td>26</td><td>46.4</td></tr><tr><td>Have you breastfed before<sup>a</sup></td><td> </td><td> </td></tr><tr><td> Yes</td><td>19</td><td>73.1<sup>b</sup></td></tr><tr><td> No</td><td>7</td><td>26.9<sup>b</sup></td></tr><tr><td>Number of infants breastfed<sup>a</sup></td><td> </td><td> </td></tr><tr><td> 0</td><td>7</td><td>26.9<sup>b</sup></td></tr><tr><td> 1</td><td>4</td><td>15.4<sup>b</sup></td></tr><tr><td> 2</td><td>3</td><td>11.5<sup>b</sup></td></tr><tr><td> ≥3</td><td>12</td><td>46.2<sup>b</sup></td></tr><tr><td>Academic qualifications</td><td> </td><td> </td></tr><tr><td> B.S.</td><td>21</td><td>37.5</td></tr><tr><td> M.S.</td><td>5</td><td>8.9</td></tr><tr><td> M.D.</td><td>28</td><td>50.0</td></tr><tr><td> Ph.D.</td><td>2</td><td>3.6</td></tr><tr><td>Specialty</td><td> </td><td> </td></tr><tr><td> Gynecology/obstetrics</td><td>10</td><td>17.9</td></tr><tr><td> Pediatrics</td><td>5</td><td>8.9</td></tr><tr><td> Family medicine</td><td>16</td><td>28.6</td></tr><tr><td> Lactation consultant nurse</td><td>13</td><td>23.2</td></tr><tr><td> Pharmacist</td><td>12</td><td>21.4</td></tr><tr><td>Number of years in practice</td><td> </td><td> </td></tr><tr><td> 5–9</td><td>23</td><td>41.1</td></tr><tr><td> ≥10</td><td>33</td><td>58.9</td></tr><tr><td>How often do you recommend herbal galactagogues for breastfeeding women?</td><td> </td><td> </td></tr><tr><td> Quite often</td><td>39</td><td>69.6</td></tr><tr><td> Sometimes</td><td>17</td><td>30.4</td></tr><tr><td>How often do you discuss herbal galactagogues that breastfeeding women could be using during your consultations with them?</td><td> </td><td> </td></tr><tr><td> Quite often</td><td>32</td><td>57.1</td></tr><tr><td> Sometimes</td><td>24</td><td>42.9</td></tr></table> |
65b0f9ba9984f5a46c6fd59d40f859b2bba027173f83f8e48d74bee21fbf2b9a.png | complex | <table><tr><td>Breakpoint type</td><td>Number</td><td>Mean distance from PQS (kb)</td><td>Mean distance from PQS in null data (kb)</td><td>Median distance from PQS (kb)</td><td>Median distance from PQS in null data (kb)</td><td>PQS association (median outside C.I.)</td></tr><tr><td rowspan="2">All</td><td>173</td><td>132.7</td><td>301 (Equal)</td><td>16.4</td><td>180.4 (Equal)</td><td>Y</td></tr><tr><td></td><td></td><td>193.8 (Unequal)</td><td>C.I. 11.1–24.3</td><td>130.5 (Unequal)</td><td>Y</td></tr><tr><td rowspan="2">All translocations</td><td>99</td><td>163.6</td><td>300.7 (Equal)</td><td>13.5</td><td>180.1 (Equal)</td><td>Y</td></tr><tr><td></td><td></td><td>193.4 (Unequal)</td><td>C.I. 5.9–53.9</td><td>130.4 (Unequal)</td><td>Y</td></tr><tr><td rowspan="2">Subtelomeric translocations only</td><td>65</td><td>109.5</td><td>300.1 (Equal)</td><td>4.8</td><td>180.6 (Equal)</td><td>Y</td></tr><tr><td></td><td></td><td>208.8 (Unequal)</td><td>C.I. 3.5–8.9</td><td>129.7 (Unequal)</td><td>Y</td></tr><tr><td rowspan="2">All <i>var</i> coding translocations</td><td>70</td><td>156.6</td><td>301.1 (Equal)</td><td>14.7</td><td>180.6 (Equal)</td><td>Y</td></tr><tr><td></td><td></td><td>181.7 (Unequal)</td><td>C.I. 4.1–18.5</td><td>125.7 (Unequal)</td><td>Y</td></tr><tr><td rowspan="2">Indels</td><td>74</td><td>91.4</td><td>300.9 (Equal)</td><td>20</td><td>179.9 (Equal)</td><td>Y</td></tr><tr><td></td><td></td><td>193.4 (Unequal)</td><td>C.I. 11.3–28.4</td><td>130.3 (Unequal)</td><td>Y</td></tr><tr><td rowspan="2"><i>Var</i>-coding events in progeny of 3D7/HB3 cross</td><td>24</td><td>56.2</td><td>300.1 (Equal)</td><td>2.9</td><td>180.7 (Equal)</td><td>Y</td></tr><tr><td></td><td></td><td>141.1 (Unequal)</td><td>C.I. 2.5–11.3</td><td>98.8 (Unequal)</td><td>Y</td></tr><tr><td rowspan="2">Analysis restricted to subtelomeres</td><td>119</td><td>91.3</td><td>133.5 (Equal)</td><td>9.1</td><td>22.8 (Equal)</td><td>Y</td></tr><tr><td></td><td></td><td>122.1 (Unequal)</td><td>C.I. 6.3–15.4</td><td>18.8 (Unequal)</td><td>Y</td></tr></table> |
ab11f03b244fe24fc59d43574f51a092c322a918732531d0e3e08bd0de60e4e2.png | complex | <table><tr><td>Sample type</td><td>Dataset</td><td>Platform</td><td>Number (Sensitivity) of HCC samples</td><td>Number (Sensitivity) ofHepatitis/cirrhotic liver samples</td></tr><tr><td rowspan="4">FFPE</td><td>GSE10142</td><td>GPL5474</td><td>-</td><td>225(0.9289)</td></tr><tr><td>GSE10186</td><td>GPL5474</td><td>118(0.9068)</td><td>-</td></tr><tr><td>GSE19977</td><td>GPL8432</td><td>164(0.9390)</td><td>-</td></tr><tr><td>GSE20017</td><td>GPL8432</td><td>135(0.9259)</td><td>-</td></tr><tr><td rowspan="8">FF</td><td>GSE63898</td><td>GPL13667</td><td>228(0.9342)</td><td>168(0.9583)</td></tr><tr><td>GSE25097</td><td>GPL10687</td><td>268(0.9478)</td><td>40(1.0000)</td></tr><tr><td>GSE56140</td><td>GPL18461</td><td>35(0.8000)</td><td>34(0.9706)</td></tr><tr><td>GSE36411</td><td>GPL10558</td><td>42(0.9524)</td><td>21(0.9524)</td></tr><tr><td>GSE6764</td><td>GPL570</td><td>35(0.9429)</td><td>13(1.0000)</td></tr><tr><td>GSE9843</td><td>GPL570</td><td>91(0.9780)</td><td>-</td></tr><tr><td>GSE17967</td><td>GPL571</td><td>-</td><td>47(1.0000)</td></tr><tr><td>GSE57725</td><td>GPL14951</td><td>-</td><td>23(0.9565)</td></tr></table> |
38c7eca2c5df400631ac55ddcb2168fe39f419164b10e21624689ac61d22d054.png | simple | <table><tr><td> </td><td>Cut-points (%) or ($)</td></tr><tr><td>Percent of population 25 and over that attended any college (Education)</td><td> </td></tr><tr><td> 1 – Low SES</td><td>0 – 39.4</td></tr><tr><td> 2</td><td>39.5 – 51.5</td></tr><tr><td> 3</td><td>51.5 – 65.9</td></tr><tr><td> 4 – High SES</td><td>65.9 – 100.0</td></tr><tr><td>Percent of housing units with one or more persons per room (Crowding)</td><td> </td></tr><tr><td> 1 – Low SES</td><td>7.6 – 65.6</td></tr><tr><td> 2</td><td>3.7 – 7.6</td></tr><tr><td> 3</td><td>1.8 – 3.7</td></tr><tr><td> 4 – High SES</td><td>0 – 1.8</td></tr><tr><td>Average per capita income in 1999 (Income)</td><td> </td></tr><tr><td> 1 – Low SES</td><td>3729 – 16 016</td></tr><tr><td> 2</td><td>16 017 – 20 040</td></tr><tr><td> 3</td><td>20 041 – 26 224</td></tr><tr><td> 4 – High SES</td><td>26 225 – 114 359</td></tr><tr><td>Percent of population in the civilian workforce that was unemployed in 1999 (Unemployment)</td><td> </td></tr><tr><td> 1 – Low SES</td><td>7.5 – 83.9</td></tr><tr><td> 2</td><td>5.0 – 7.5</td></tr><tr><td> 3</td><td>3.5 – 5.0</td></tr><tr><td> 4 – High SES</td><td>0 – 3.4</td></tr></table> |
2624d670c210b1e56153bbfc373d24faddf497eadc92e8ecc8448a116ab37528.png | complex | <table><tr><td rowspan="2">Nutrient</td><td colspan="3">Adolescent boys component</td><td colspan="3">Adolescent girls component</td></tr><tr><td>1</td><td>2</td><td>3</td><td>1</td><td>2</td><td>3</td></tr><tr><td>Proteins (g)</td><td>0.86</td><td>0.04</td><td>0.35</td><td>0.82</td><td>0.45</td><td>0.05</td></tr><tr><td>Total fat (g)</td><td>0.48</td><td>0.18</td><td>0.34</td><td>0.17</td><td>0.91</td><td>−0.00</td></tr><tr><td>Energy (Kcal)</td><td>0.93</td><td>0.05</td><td>0.13</td><td>0.92</td><td>0.21</td><td>−0.01</td></tr><tr><td>Calcium (mg)</td><td>0.02</td><td>0.16</td><td>0.87</td><td>0.00</td><td>0.92</td><td>0.16</td></tr><tr><td>Iron (mg)</td><td>0.39</td><td>0.00</td><td>0.60</td><td>0.38</td><td>0.45</td><td>0.05</td></tr><tr><td>Vitamin A (mg)</td><td>0.10</td><td>0.90</td><td>0.16</td><td>0.00</td><td>0.07</td><td>0.93</td></tr><tr><td>Thiamine (mg)</td><td>0.93</td><td>0.07</td><td>0.13</td><td>0.95</td><td>0.05</td><td>0.06</td></tr><tr><td>Riboflavin (mg)</td><td>0.77</td><td>0.41</td><td>0.21</td><td>0.71</td><td>0.14</td><td>0.50</td></tr><tr><td>Niacin (mg)</td><td>0.92</td><td>0.06</td><td>0.04</td><td>0.92</td><td>−0.00</td><td>0.03</td></tr><tr><td>Vitamin C (mg)</td><td>0.15</td><td>0.87</td><td>0.04</td><td>0.07</td><td>0.03</td><td>0.87</td></tr><tr><td>Free folic acid (μg)</td><td>0.71</td><td>0.35</td><td>0.07</td><td>0.61</td><td>0.14</td><td>0.51</td></tr><tr><td>Eigen value</td><td>5.7</td><td>1.6</td><td>1.0</td><td>5.2</td><td>1.8</td><td>1.8</td></tr><tr><td>Variance explained</td><td>51.8</td><td>14.5</td><td>9.3</td><td>47.2</td><td>17.0</td><td>15.4</td></tr></table> |
51db1cfcbd5ca674cd9f12296477729dfc30004613fdc0aa443ed1290c428321.png | simple | <table><tr><td>Source</td><td>Sum of squares</td><td>d.f.</td><td>Mean square</td><td><i>F</i>-value</td><td><i>p</i>-value</td></tr><tr><td>Level of training</td><td>113.270</td><td>2</td><td>56.635</td><td>13.382*</td><td>.000</td></tr><tr><td>Score in dimensions of mini-CEX</td><td>33.810</td><td>5.566</td><td>6.075</td><td>29.153*</td><td>.000</td></tr><tr><td>Level of training x Dimensions of mini-CEX</td><td>8.161</td><td>11.132</td><td>0.733</td><td>3.518*</td><td>.000</td></tr><tr><td>Error</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Between subjects</td><td>3457.727</td><td>817</td><td>4.232</td><td> </td><td> </td></tr><tr><td>Residual Error</td><td>947.520</td><td>4547.337</td><td>0.208</td><td> </td><td> </td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.